Track market-moving stories before they get noisy

Key Takeaways Astronics' Military Aircraft sales rose 11.7% to $30.6 million on higher flight-critical power sales.Astronics booked $27.4 million for the MV-75 FLRAA engineering phase, supporting its defense exposure.Test Systems posted $63.1 million in bookings and a 2.78:1 book-to-bill ratio in the quarter. Astronics (ATRO - Free Report) is expanding its participation in military aerospace through flight-critical power technologies and new aircraft programs. While commercial transport remains an important part of the company's Aerospace business, its Military Aircraft operations are gaining from demand for power systems used on military platforms. During the second quarter of 2026, Astronics' Military Aircraft sales increased 11.7% to $30.6 million, driven by higher sales of flight-critical airframe power products.

A key development during the quarter was the MV-75 Future Long-Range Assault Aircraft (“FLRAA”) program. Astronics finalized the contract for the current engineering phase of the program, resulting in a $27.4 million booking. The booking was included in Aerospace bookings of $243.1 million for the quarter, while the Aerospace segment ended the period with a record $657.2 million backlog.

The FLRAA program is particularly relevant because Astronics is participating in the aircraft’s development phase. The company continues to perform well on the program and expects development to be completed in mid-2027. This positions Astronics to continue supplying its capabilities as the aircraft progresses through development.

The Test Systems order also illustrates how Astronics' defense exposure extends beyond aircraft components. The segment recorded $63.1 million of bookings during the second quarter, including the Army order, resulting in a 2.78:1 book-to-bill ratio. Segment backlog reached $123.3 million at the end of the quarter.

The company's flight-critical power, MV-75 engineering program and U.S. Army test-equipment business give Astronics multiple avenues to support military aerospace modernization.

Companies Supplying Next-Generation Military AircraftAlong with ATRO, several other aerospace and defense companies are also supplying technologies for new military aircraft programs.

Honeywell Aerospace Inc. (HONA - Free Report) develops aerospace systems and technologies used across military and commercial aircraft, including avionics, propulsion-related systems and auxiliary power technologies.

Moog (MOG.A - Free Report) supplies precision motion-control and flight-control technologies for military aircraft, missiles, space systems and commercial aerospace platforms.

ATRO Stock’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates a year-over-year improvement of 64.07% and 16.3%, respectively.

Image Source: Zacks Investment Research

ATRO Stock Trades at a DiscountIn terms of valuation, ATRO’s forward 12-month price-to-sales (P/S) is 2.71X, a discount to the industry’s average of 7.11X.

Image Source: Zacks Investment Research

ATRO Stock’s Price PerformanceIn the past six months, the company’s shares have risen 30% against the industry’s 4.8% decline.

Image Source: Zacks Investment Research

ATRO’s Zacks RankThe company currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 1.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 104,001,309 shares of the iPhone maker’s stock after selling 1,509,444 shares during the period. Apple makes up about 5.5% of UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s investment portfolio, making the stock its 2nd largest position. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.71% of Apple worth $30,093,819,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AAPL. Prospect Hill Management LLC acquired a new stake in Apple during the 2nd quarter worth about $146,370,000. Focus Partners Advisor Solutions LLC acquired a new position in shares of Apple in the second quarter worth about $168,646,000. Wealthfront Advisers LLC purchased a new position in shares of Apple in the second quarter worth approximately $482,388,000. Satovsky Asset Management LLC acquired a new stake in shares of Apple during the second quarter valued at approximately $16,064,000. Finally, Saranac Partners Ltd purchased a new stake in shares of Apple in the 2nd quarter valued at approximately $9,513,000. 67.73% of the stock is owned by institutional investors and hedge funds.

Apple Trading Up 1.1% Apple stock opened at $333.02 on Thursday. Apple Inc. has a 12 month low of $243.42 and a 12 month high of $345.34. The company has a quick ratio of 0.93, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The stock has a market cap of $4.86 trillion, a P/E ratio of 38.19, a P/E/G ratio of 2.86 and a beta of 1.08. The company’s fifty day simple moving average is $321.97 and its 200-day simple moving average is $299.21.

Apple (NASDAQ:AAPL – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The iPhone maker reported $2.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.13. The business had revenue of $109.42 billion during the quarter, compared to analyst estimates of $109.04 billion. Apple had a return on equity of 135.46% and a net margin of 27.62%.Apple’s quarterly revenue was up 16.4% compared to the same quarter last year. During the same period last year, the company earned $1.57 earnings per share. As a group, sell-side analysts forecast that Apple Inc. will post 8.74 EPS for the current fiscal year. Apple Announces Dividend The company also recently declared a quarterly dividend, which was paid on Thursday, August 13th. Stockholders of record on Monday, August 10th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Monday, August 10th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.3%. Apple’s dividend payout ratio (DPR) is 12.39%.

Wall Street Analysts Forecast Growth A number of equities analysts recently commented on the stock. Morgan Stanley reaffirmed an “overweight” rating and issued a $360.00 price objective on shares of Apple in a research note on Tuesday. Jefferies Financial Group reaffirmed an “underperform” rating on shares of Apple in a research report on Wednesday, September 9th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Apple in a report on Friday, September 25th. Raymond James Financial reissued a “market perform” rating on shares of Apple in a research report on Friday, July 31st. Finally, KeyCorp reissued an “underweight” rating on shares of Apple in a research note on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $340.14.

Check Out Our Latest Report on AAPL

Key Apple News Here are the key news stories impacting Apple this week:

Positive Sentiment: Counterpoint Research estimates Apple could sell approximately 6 million iPhone Duo foldable handsets in 2026, despite the device’s premium starting price of $1,999. Pre-orders reportedly begin October 16, with deliveries scheduled for October 23. Apple Predicted To Sell 6 Million iPhone Duo Handsets This Year Positive Sentiment: Early iPhone 18 Pro demand in China is encouraging: first-week sales rose 12% year over year, and Apple captured 33% of smartphone sales during the measured period. Analysts also see consumers showing greater willingness to pay for higher-priced models. Apple iPhone 18 Pro China Launch-Week Sales Rise 12% Positive Sentiment: Reports that Apple will unveil a new smart-home hub at an October 13 event added to expectations for expansion beyond the iPhone. The company is also reportedly renewing its Qualcomm licensing agreement, supporting continuity for its device and connectivity roadmap. Apple Plans Smart-Home Push Positive Sentiment: Broader technology stocks benefited from cooler inflation data, which reduced near-term concerns about additional Federal Reserve rate hikes. Apple also received a favorable endorsement from Jim Cramer ahead of the Duo launch. Neutral Sentiment: New CEO John Ternus is reportedly considering an engineering-focused restructuring, faster product releases and fewer management layers. The changes could improve innovation and execution, but they introduce transition risk and may include layoffs as memory costs rise. Apple’s New CEO Plans Overhaul Negative Sentiment: Bank of America warned that Meta’s Muse and other AI agents could divert product discovery, shopping activity and services revenue away from Apple’s ecosystem, increasing pressure on Siri, Apple Pay and the App Store. Negative Sentiment: Apple patched a zero-day vulnerability reportedly used in targeted attacks involving iPhone crypto wallets. In addition, a UK class-action case over marketplace restrictions was allowed to proceed, creating ongoing legal and reputational risks. Insider Buying and Selling at Apple In other news, SVP Jennifer Newstead sold 2,399 shares of Apple stock in a transaction dated Tuesday, September 22nd. The stock was sold at an average price of $340.06, for a total transaction of $815,803.94. Following the completion of the sale, the senior vice president directly owned 44,391 shares in the company, valued at $15,095,603.46. The trade was a 5.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders sold 11,031 shares of company stock worth $3,535,759. 0.06% of the stock is owned by company insiders.

Apple Profile (Free Report)

Apple Inc is a technology company that designs, develops and markets consumer electronics, software and digital services. Its best-known products include the iPhone smartphone, Mac personal computers, iPad tablets, Apple Watch, AirPods and other accessories. The company also develops operating systems and software platforms, including iOS, macOS, iPadOS, watchOS and visionOS.

Apple’s services business includes the App Store, Apple Music, Apple TV+, Apple Arcade, Apple News+, Apple Fitness+ and iCloud.

Featured Articles Five stocks we like better than Apple Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test

Receive News & Ratings for Apple Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple and related companies with MarketBeat.com's FREE daily email newsletter.

Apple already turned $1,000 into more than $12,000 once, but doing it again from today's price is a very different challenge. The math on how long a 10x return actually takes reveals just how much has changed for this stock.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A 10x return means turning $1,000 into $10,000. It has already been done once by Apple (NASDAQ:AAPL | AAPL Price Prediction). Over the past decade the stock returned 1181.3%, so a $1,000 investment grew to about $12,813. Shares traded at $331.22 in Tuesday’s session.

The price model starts from the prior close of $338.25. Our longest forecast period ends in 2031, so every concrete figure below is linked to that five-year window.

What $1,000 in Apple Could Become by 2031 Under the central scenario, a $1,000 investment could be worth about $1,626.60 by 2031. The total return comes to 62.66%. It rests on a five-year per-share target of $550.18, which works out to an annualized return of 10.22%.

So how long until the investment hits $10,000? This part is illustrative only, because the model does not forecast that far out. If Apple kept growing at the base-case pace, a 10x gain would take about 23.6628 years.

At the bull-case pace it would take 17.1491 years. At the bear-case pace it would take 84.8765 years. A company this large growing more slowly than it did during its last tenfold run.

Bull, Base and Bear Scenarios for a $1,000 Stake Scenario (5-Year, 2031) Target Price Total Return Annualized Value of $1,000 Bull $661.78 95.65% 14.37% $1,956.50 Base $550.18 62.66% 10.22% $1,626.60 Bear $387.38 14.52% 2.75% $1,145.20 The one-year view is shorter. The most best scenario reaches $446.90 ($1,321.20 for the investment). The central scenario reaches $393.86 ($1,164.40). The most worst scenario reaches $338.86 ($1,001.80).

The model rates its confidence as high (0.9). Because Apple is a mega-cap, the model also applies a 50% reduction to its growth adjustment. It is a projection, not investment advice.

Three Drivers Behind the Upside Case Earnings Keep Beating Expectations Apple has exceeded EPS estimates for 10 consecutive quarters. In fiscal Q3 it earned $2.02 per share against a $1.8914 estimate. Revenue came in at $109.42B, up 16.36% from a year earlier. iPhone revenue rose 22% on the iPhone 17 family. The CEO called it “the most powerful and most popular iPhone lineup we’ve ever had.”

Services and Siri AI Build Recurring Revenue Services brought in $30.7 billion, up 12%, and paid subscriptions passed 1.5 billion. Apple introduced a redesigned Siri AI at WWDC. Management plans iCloud+ upgrade options for heavy users, which could add a new subscription revenue stream.

Cash Returned to Shareholders The board authorized an additional $100B buyback and raised the quarterly dividend to $0.27. Buybacks reduce the share count, so each remaining share gets a larger piece of earnings. It also relies on forward EPS of $9.1636 and a forward P/E of about 37x.

What Wall Street Analysts Expect Sentiment leans positive. Analysts rate Apple 6 strong buy, 19 buy, 14 hold, 3 sell and 2 strong sell. The consensus target of $328.22 sits below the current share price, though.

In other words, analysts on average see the stock as close to fully valued right now. The model’s upside comes mostly from earnings growth, while the consensus target means little room for the valuation multiple to rise.

Risks That Could Shrink Your Returns Valuation leaves little room for error. Apple trades at about 44 times trailing earnings. Supply is also tight: management expects constraints to “increase significantly” across iPhone, Mac and iPad. The CEO described rising memory prices as “a 100-year flood on the memory pricing.”

Recent results also got a one-time lift. Tariff refunds added about 2 pts to gross margin and $0.11 to EPS, and that benefit will not repeat. For the September quarter, guidance calls for revenue growth of 9% to 11%. That is slower than recent quarters.

Regulation is another pressure point. Siri AI still needs more work before it can launch in China, and in the EU its availability depends on talks with the European Commission. App Store decisions are already weighing on Services.

Competition in AI is heating up too: Bank of America noted an AI threat to Apple from Meta’s Muse. If these pressures build up, the most worst scenario of $1,145.20 becomes the more realistic outcome.

How Long Until $1,000 Becomes $10,000 The model’s five-year scenarios put $1,000 in Apple between $1,145.20 and $1,956.50 by 2031. The central scenario is $1,626.60.

Reaching $10,000 at the forecast pace would take well over a decade, and that timeline is only illustrative. They are scenarios, not guarantees. The next earnings report, along with updates on supply and memory costs, will show which path Apple is on.

Contact [email protected] for any questions or corrections.

Talon Private Wealth LLC boosted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 136.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,008 shares of the social networking company’s stock after acquiring an additional 2,315 shares during the quarter. Talon Private Wealth LLC’s holdings in Meta Platforms were worth $2,258,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in META. Marathon Wealth Advisors LLC lifted its stake in Meta Platforms by 4.3% in the second quarter. Marathon Wealth Advisors LLC now owns 7,016 shares of the social networking company’s stock valued at $3,952,000 after acquiring an additional 287 shares during the last quarter. Junto Capital Management LP increased its stake in shares of Meta Platforms by 104.1% during the 2nd quarter. Junto Capital Management LP now owns 110,841 shares of the social networking company’s stock worth $62,436,000 after purchasing an additional 56,537 shares during the last quarter. Miramontes Capital LLC increased its stake in shares of Meta Platforms by 7.1% during the 2nd quarter. Miramontes Capital LLC now owns 4,813 shares of the social networking company’s stock worth $2,711,000 after purchasing an additional 321 shares during the last quarter. Core Capital Management & Research inc. bought a new stake in shares of Meta Platforms in the 2nd quarter valued at about $348,000. Finally, Capstone Financial Advisors Inc. raised its holdings in shares of Meta Platforms by 10.5% in the 2nd quarter. Capstone Financial Advisors Inc. now owns 3,345 shares of the social networking company’s stock valued at $1,884,000 after purchasing an additional 318 shares during the period. Institutional investors and hedge funds own 79.91% of the company’s stock.

Meta Platforms Trading Down 1.6% Shares of Meta Platforms stock opened at $726.91 on Thursday. The firm has a 50-day moving average of $620.47 and a 200-day moving average of $614.49. The stock has a market cap of $1.85 trillion, a PE ratio of 27.38, a PEG ratio of 1.29 and a beta of 1.25. Meta Platforms, Inc. has a 52-week low of $520.26 and a 52-week high of $779.82. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.23 and a current ratio of 2.23.

Meta Platforms (NASDAQ:META – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The social networking company reported $6.18 EPS for the quarter, missing the consensus estimate of $7.19 by ($1.01). Meta Platforms had a net margin of 29.83% and a return on equity of 33.18%. The business had revenue of $60.80 billion during the quarter, compared to analyst estimates of $60.22 billion. During the same quarter last year, the company posted $7.14 earnings per share. The company’s revenue was up 28.0% on a year-over-year basis. As a group, sell-side analysts forecast that Meta Platforms, Inc. will post 27.94 EPS for the current year. Meta Platforms Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, September 28th. Shareholders of record on Monday, September 21st were given a dividend of $0.5250 per share. This represents a $2.10 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, September 21st. Meta Platforms’s dividend payout ratio is presently 7.91%.

Insider Activity at Meta Platforms In other Meta Platforms news, insider Christopher K. Cox sold 40,000 shares of the firm’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $712.76, for a total transaction of $28,510,400.00. Following the transaction, the insider owned 184,516 shares in the company, valued at $131,515,624.16. This trade represents a 17.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Javier Olivan sold 3,348 shares of Meta Platforms stock in a transaction on Monday, July 6th. The shares were sold at an average price of $600.97, for a total value of $2,012,047.56. Following the completion of the transaction, the chief operating officer directly owned 9,498 shares of the company’s stock, valued at $5,708,013.06. This represents a 26.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 151,882 shares of company stock valued at $103,032,319. 13.53% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In META has been the subject of a number of research analyst reports. Susquehanna reduced their price target on Meta Platforms from $900.00 to $650.00 and set a “positive” rating for the company in a report on Thursday, July 30th. Guggenheim reissued a “buy” rating and set a $800.00 price target on shares of Meta Platforms in a research report on Tuesday, July 28th. Cantor Fitzgerald upped their price objective on Meta Platforms from $680.00 to $860.00 and gave the company an “overweight” rating in a research note on Wednesday, September 23rd. DZ Bank reaffirmed a “buy” rating on shares of Meta Platforms in a research report on Thursday, July 30th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $725.00 target price (down from $815.00) on shares of Meta Platforms in a research note on Thursday, August 27th. Three research analysts have rated the stock with a Strong Buy rating, forty-four have issued a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Meta Platforms currently has a consensus rating of “Moderate Buy” and an average price target of $787.86.

View Our Latest Stock Report on META

Meta Platforms News Summary Here are the key news stories impacting Meta Platforms this week:

Positive Sentiment: Meta is expanding its Muse AI agent to small businesses with integrations including Shopify, QuickBooks, Stripe, Canva, Slack and Dropbox. The move could diversify revenue beyond advertising and create opportunities in subscriptions, transaction fees and enterprise software. Meta expands Muse AI agent for small businesses Positive Sentiment: Analysts continue to view Muse as a potential multibillion-dollar growth catalyst, citing early adoption, integration across Meta’s apps and possible commercial API and subscription revenue. AI tools are also expected to improve advertising engagement and conversions. Analysts align on Meta Muse as a growth catalyst Positive Sentiment: Strategists argue Meta could be relatively resilient if AI infrastructure spending slows because it is using AI to enhance an existing advertising business rather than relying solely on hardware sales. A reported $27 billion AI-capacity agreement with Nebius also underscores continued infrastructure investment. Nvidia AI capex and Meta Neutral Sentiment: COO Javier Olivan sold shares under a pre-arranged Rule 10b5-1 plan. The transactions reduced his holdings, but scheduled sales generally provide a weaker signal than discretionary insider trading. SEC insider ownership filing Negative Sentiment: OpenAI launched Dots, an always-on AI agent positioned against Muse, raising concerns that Meta’s newest growth story could face powerful competition from OpenAI, Google and Apple. OpenAI follows Meta into personal agents Negative Sentiment: Reports alleging that Muse accessed private messages without permission have created privacy and reputational concerns, although Meta disputes the claims. Investors are also monitoring heavy AI and data-center spending, a recent quarterly EPS miss, and questions over whether the investment will generate sufficient returns. Meta disputes Muse privacy claim Negative Sentiment: CEO Mark Zuckerberg separately sold approximately $21.4 million of stock under a Rule 10b5-1 plan. While scheduled, the sale may add to short-term investor caution following the stock’s sharp rally. Mark Zuckerberg stock sale Meta Platforms Company Profile (Free Report)

Meta Platforms, Inc is a technology company that develops social networking, messaging, virtual and augmented reality, and artificial intelligence products. The company operates a global family of apps that includes Facebook, Instagram, Messenger, WhatsApp and Threads, enabling users to connect, communicate, share content and discover communities.

Meta generates most of its business through digital advertising displayed across its platforms. Its products serve individuals, creators, businesses and organizations in markets around the world, while its advertising tools help businesses reach audiences based on factors such as interests, activity and demographics.

Through its Reality Labs division, Meta develops virtual and augmented reality hardware, software and services, including the Meta Quest line of headsets and related experiences.

Recommended Stories Five stocks we like better than Meta Platforms Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test

Receive News & Ratings for Meta Platforms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meta Platforms and related companies with MarketBeat.com's FREE daily email newsletter.

The Manufacturers Life Insurance Company lessened its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,878,365 shares of the social networking company’s stock after selling 139,263 shares during the quarter. Meta Platforms makes up about 0.8% of The Manufacturers Life Insurance Company’s holdings, making the stock its 17th biggest holding. The Manufacturers Life Insurance Company owned 0.11% of Meta Platforms worth $1,621,353,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in META. Watchman Group Inc. boosted its position in shares of Meta Platforms by 0.3% in the first quarter. Watchman Group Inc. now owns 5,091 shares of the social networking company’s stock worth $2,913,000 after buying an additional 15 shares during the period. Penney Financial LLC raised its position in Meta Platforms by 3.9% during the first quarter. Penney Financial LLC now owns 399 shares of the social networking company’s stock valued at $228,000 after buying an additional 15 shares during the period. Barnes Pettey Financial Advisors LLC raised its position in Meta Platforms by 1.0% during the first quarter. Barnes Pettey Financial Advisors LLC now owns 1,519 shares of the social networking company’s stock valued at $869,000 after buying an additional 15 shares during the period. CWS Financial Advisors LLC lifted its stake in Meta Platforms by 1.7% in the 1st quarter. CWS Financial Advisors LLC now owns 985 shares of the social networking company’s stock worth $564,000 after acquiring an additional 16 shares in the last quarter. Finally, Tenzing Financial LLC lifted its stake in Meta Platforms by 1.3% in the 2nd quarter. Tenzing Financial LLC now owns 1,210 shares of the social networking company’s stock worth $726,000 after acquiring an additional 16 shares in the last quarter. Institutional investors and hedge funds own 79.91% of the company’s stock.

Analysts Set New Price Targets Several equities analysts have recently commented on META shares. Guggenheim restated a “buy” rating and set a $800.00 price target on shares of Meta Platforms in a report on Tuesday, July 28th. Wolfe Research reissued an “outperform” rating and set a $700.00 price objective on shares of Meta Platforms in a research report on Thursday, July 30th. Citic Securities lowered their target price on Meta Platforms from $770.00 to $718.00 and set a “buy” rating on the stock in a research note on Monday, August 3rd. Piper Sandler upped their target price on Meta Platforms from $785.00 to $875.00 and gave the stock an “overweight” rating in a research report on Friday, September 25th. Finally, Truist Financial cut their price target on Meta Platforms from $770.00 to $763.00 and set a “buy” rating for the company in a research note on Thursday, August 27th. Three analysts have rated the stock with a Strong Buy rating, forty-four have issued a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $787.86.

View Our Latest Analysis on Meta Platforms Insiders Place Their Bets In related news, CFO Susan Li sold 9,196 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $550.61, for a total value of $5,063,409.56. Following the completion of the sale, the chief financial officer directly owned 13,186 shares in the company, valued at approximately $7,260,343.46. The trade was a 41.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Zuckerberg sold 27,474 shares of the company’s stock in a transaction that occurred on Thursday, September 24th. The stock was sold at an average price of $777.44, for a total value of $21,359,386.56. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 151,882 shares of company stock worth $103,032,319 in the last three months. 13.53% of the stock is owned by insiders.

Meta Platforms Trading Down 1.6% Shares of NASDAQ:META opened at $726.91 on Thursday. The stock has a market capitalization of $1.85 trillion, a PE ratio of 27.38, a P/E/G ratio of 1.29 and a beta of 1.25. Meta Platforms, Inc. has a 1 year low of $520.26 and a 1 year high of $779.82. The firm has a fifty day moving average price of $620.47 and a 200 day moving average price of $614.49. The company has a current ratio of 2.23, a quick ratio of 2.23 and a debt-to-equity ratio of 0.32.

Meta Platforms (NASDAQ:META – Get Free Report) last posted its earnings results on Wednesday, July 29th. The social networking company reported $6.18 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($1.01). Meta Platforms had a net margin of 29.83% and a return on equity of 33.18%. The company had revenue of $60.80 billion for the quarter, compared to the consensus estimate of $60.22 billion. During the same quarter last year, the business earned $7.14 earnings per share. Meta Platforms’s quarterly revenue was up 28.0% on a year-over-year basis. Analysts expect that Meta Platforms, Inc. will post 27.94 EPS for the current fiscal year.

Meta Platforms Dividend Announcement The business also recently disclosed a quarterly dividend, which was paid on Monday, September 28th. Stockholders of record on Monday, September 21st were issued a dividend of $0.5250 per share. The ex-dividend date of this dividend was Monday, September 21st. This represents a $2.10 dividend on an annualized basis and a dividend yield of 0.3%. Meta Platforms’s dividend payout ratio is currently 7.91%.

Trending Headlines about Meta Platforms Here are the key news stories impacting Meta Platforms this week:

Positive Sentiment: Meta is expanding its Muse AI agent to small businesses with integrations including Shopify, QuickBooks, Stripe, Canva, Slack and Dropbox. The move could diversify revenue beyond advertising and create opportunities in subscriptions, transaction fees and enterprise software. Meta expands Muse AI agent for small businesses Positive Sentiment: Analysts continue to view Muse as a potential multibillion-dollar growth catalyst, citing early adoption, integration across Meta’s apps and possible commercial API and subscription revenue. AI tools are also expected to improve advertising engagement and conversions. Analysts align on Meta Muse as a growth catalyst Positive Sentiment: Strategists argue Meta could be relatively resilient if AI infrastructure spending slows because it is using AI to enhance an existing advertising business rather than relying solely on hardware sales. A reported $27 billion AI-capacity agreement with Nebius also underscores continued infrastructure investment. Nvidia AI capex and Meta Neutral Sentiment: COO Javier Olivan sold shares under a pre-arranged Rule 10b5-1 plan. The transactions reduced his holdings, but scheduled sales generally provide a weaker signal than discretionary insider trading. SEC insider ownership filing Negative Sentiment: OpenAI launched Dots, an always-on AI agent positioned against Muse, raising concerns that Meta’s newest growth story could face powerful competition from OpenAI, Google and Apple. OpenAI follows Meta into personal agents Negative Sentiment: Reports alleging that Muse accessed private messages without permission have created privacy and reputational concerns, although Meta disputes the claims. Investors are also monitoring heavy AI and data-center spending, a recent quarterly EPS miss, and questions over whether the investment will generate sufficient returns. Meta disputes Muse privacy claim Negative Sentiment: CEO Mark Zuckerberg separately sold approximately $21.4 million of stock under a Rule 10b5-1 plan. While scheduled, the sale may add to short-term investor caution following the stock’s sharp rally. Mark Zuckerberg stock sale Meta Platforms Profile (Free Report)

Meta Platforms, Inc is a technology company that develops social networking, messaging, virtual and augmented reality, and artificial intelligence products. The company operates a global family of apps that includes Facebook, Instagram, Messenger, WhatsApp and Threads, enabling users to connect, communicate, share content and discover communities.

Meta generates most of its business through digital advertising displayed across its platforms. Its products serve individuals, creators, businesses and organizations in markets around the world, while its advertising tools help businesses reach audiences based on factors such as interests, activity and demographics.

Through its Reality Labs division, Meta develops virtual and augmented reality hardware, software and services, including the Meta Quest line of headsets and related experiences.

Recommended Stories Five stocks we like better than Meta Platforms Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test Want to see what other hedge funds are holding META? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Meta Platforms, Inc. (NASDAQ:META – Free Report).

Receive News & Ratings for Meta Platforms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meta Platforms and related companies with MarketBeat.com's FREE daily email newsletter.

McAdam LLC raised its holdings in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 7.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,744 shares of the software giant’s stock after buying an additional 1,758 shares during the period. Microsoft comprises about 0.4% of McAdam LLC’s holdings, making the stock its 21st largest position. McAdam LLC’s holdings in Microsoft were worth $9,603,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Auto Owners Insurance Co raised its position in shares of Microsoft by 56,160.8% during the 4th quarter. Auto Owners Insurance Co now owns 60,116,384 shares of the software giant’s stock worth $29,073,486,000 after acquiring an additional 60,009,531 shares in the last quarter. Corient Private Wealth LLC boosted its holdings in Microsoft by 234.5% in the fourth quarter. Corient Private Wealth LLC now owns 17,822,280 shares of the software giant’s stock valued at $8,619,211,000 after purchasing an additional 12,493,786 shares in the last quarter. Amundi increased its stake in Microsoft by 30.8% in the first quarter. Amundi now owns 41,675,076 shares of the software giant’s stock valued at $15,426,862,000 after purchasing an additional 9,814,598 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in Microsoft by 64.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 24,264,779 shares of the software giant’s stock valued at $8,982,083,000 after purchasing an additional 9,493,778 shares during the last quarter. Finally, Diamant Asset Management Inc. raised its holdings in Microsoft by 38,442.1% during the first quarter. Diamant Asset Management Inc. now owns 6,810,388 shares of the software giant’s stock worth $2,521,001,000 after purchasing an additional 6,792,718 shares in the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling In other news, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the sale, the chief executive officer owned 100,447 shares in the company, valued at approximately $49,007,086.83. This trade represents a 9.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Satya Nadella sold 86,525 shares of Microsoft stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $501.46, for a total transaction of $43,388,826.50. Following the completion of the sale, the chief executive officer directly owned 486,763 shares in the company, valued at approximately $244,092,173.98. The trade was a 15.09% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 143,009 shares of company stock valued at $71,420,699 in the last ninety days. Company insiders own 0.03% of the company’s stock.

Key Headlines Impacting Microsoft Here are the key news stories impacting Microsoft this week: Positive Sentiment: Piper Sandler raised its price target to $610 from $550 and maintained an Overweight rating, citing improving estimates for Microsoft’s commercial cloud business and potential revenue from the new E7 enterprise licensing tier. Why is Microsoft stock up on Wednesday? Positive Sentiment: Microsoft’s revamped Copilot is becoming more enterprise-focused, while usage-based billing expected to begin in November could simplify adoption and improve monetization. Analysts also see potential for paid Copilot seats to continue expanding rapidly. What a Revamped Copilot Means for Microsoft Stock Positive Sentiment: Microsoft is bringing OpenAI’s autonomous “Dots” agents into its enterprise security and governance framework, strengthening its position in workplace AI. A long-term Xbox publishing agreement with Take-Two also supports the gaming ecosystem. Microsoft Brings OpenAI’s Autonomous Dots AI Workers Into the Enterprise Neutral Sentiment: Microsoft has delivered a substantial quarterly rally, but its valuation remains below its recent average P/E despite strong Azure growth, expanding Copilot demand and a sizable commercial backlog. This leaves room for additional upside, although expectations are already elevated. How Much Upside Is Left In Microsoft Stock? Negative Sentiment: Investors remain concerned that surging AI infrastructure spending could outpace free cash flow before Azure and Copilot returns fully materialize. Microsoft also warns that AI agents may weaken traditional software pricing power and customer loyalty. The AI Revolution Could Be Microsoft’s Next Trillion-Dollar Opportunity Wall Street Analyst Weigh In Several brokerages have recently issued reports on MSFT. Cantor Fitzgerald upped their target price on shares of Microsoft from $522.00 to $608.00 and gave the company an “overweight” rating in a report on Monday, September 21st. Barclays cut their price target on shares of Microsoft from $545.00 to $512.00 and set an “overweight” rating on the stock in a research note on Thursday, July 30th. Jefferies Financial Group reissued a “buy” rating on shares of Microsoft in a research report on Monday, September 21st. Benchmark restated a “buy” rating on shares of Microsoft in a research note on Friday, July 24th. Finally, Piper Sandler raised their price objective on Microsoft from $550.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday. Forty-three research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $570.62.

Check Out Our Latest Research Report on MSFT

Microsoft Stock Performance NASDAQ MSFT opened at $512.90 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07. Microsoft Corporation has a 52-week low of $349.20 and a 52-week high of $553.72. The business’s 50-day moving average price is $484.74 and its 200 day moving average price is $428.53. The firm has a market cap of $3.81 trillion, a P/E ratio of 28.56, a P/E/G ratio of 1.64 and a beta of 1.11.

Microsoft (NASDAQ:MSFT – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, beating the consensus estimate of $4.24 by $0.50. Microsoft had a return on equity of 31.98% and a net margin of 40.31%.The firm had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. During the same period in the prior year, the business earned $3.65 EPS. The firm’s revenue was up 17.7% compared to the same quarter last year. On average, equities research analysts expect that Microsoft Corporation will post 19.62 earnings per share for the current year.

Microsoft Increases Dividend The business also recently declared a quarterly dividend, which will be paid on Thursday, December 10th. Stockholders of record on Thursday, November 19th will be paid a dividend of $0.98 per share. This represents a $3.92 annualized dividend and a dividend yield of 0.8%. This is a boost from Microsoft’s previous quarterly dividend of $0.91. The ex-dividend date is Thursday, November 19th. Microsoft’s dividend payout ratio (DPR) is currently 20.27%.

About Microsoft (Free Report)

Microsoft Corporation is a global technology company that develops software, cloud services, devices, gaming products and business solutions. Founded in 1975 by Bill Gates and Paul Allen, the company is best known for the Windows operating system and Microsoft Office productivity software. Microsoft is headquartered in Redmond, Washington, and serves consumers, businesses, governments and educational institutions worldwide.

Microsoft’s productivity and business offerings include Microsoft 365 applications such as Word, Excel, PowerPoint and Outlook, along with collaboration tools including Teams.

Recommended Stories Five stocks we like better than Microsoft Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).

Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.

Quent Capital LLC boosted its position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 8.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 135,244 shares of the computer hardware maker’s stock after acquiring an additional 10,144 shares during the period. NVIDIA accounts for about 1.7% of Quent Capital LLC’s investment portfolio, making the stock its 11th largest position. Quent Capital LLC’s holdings in NVIDIA were worth $27,061,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in NVDA. J. Stern & Co. LLP raised its position in shares of NVIDIA by 13,709.1% during the 4th quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock valued at $23,454,297,000 after purchasing an additional 124,849,603 shares during the period. Amundi boosted its holdings in NVIDIA by 10.4% in the 1st quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after buying an additional 12,575,177 shares during the period. SEB Asset Management AB bought a new position in NVIDIA in the 1st quarter worth $1,692,807,000. Employees Provident Fund Board purchased a new stake in NVIDIA in the 4th quarter worth $1,243,336,000. Finally, H&H International Investment LLC raised its holdings in NVIDIA by 91.3% during the first quarter. H&H International Investment LLC now owns 13,843,775 shares of the computer hardware maker’s stock valued at $2,414,354,000 after acquiring an additional 6,606,675 shares during the period. Hedge funds and other institutional investors own 65.27% of the company’s stock.

Analyst Upgrades and Downgrades NVDA has been the topic of several research analyst reports. Royal Bank Of Canada boosted their price objective on NVIDIA from $300.00 to $330.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. DZ Bank reiterated a “buy” rating on shares of NVIDIA in a research report on Wednesday, August 26th. Melius Research set a $420.00 target price on NVIDIA in a research note on Thursday, August 27th. Cantor Fitzgerald reissued an “overweight” rating and issued a $350.00 price target on shares of NVIDIA in a report on Monday, August 24th. Finally, Jefferies Financial Group restated a “buy” rating on shares of NVIDIA in a research note on Wednesday, August 26th. Four equities research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $324.14.

View Our Latest Stock Analysis on NVDA Insider Activity at NVIDIA In other NVIDIA news, Director Mark A. Stevens sold 622,239 shares of the stock in a transaction on Friday, September 4th. The shares were sold at an average price of $231.62, for a total transaction of $144,122,997.18. Following the completion of the transaction, the director owned 2,336,531 shares in the company, valued at $541,187,310.22. This trade represents a 21.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Timothy S. Teter sold 30,460 shares of NVIDIA stock in a transaction on Monday, September 21st. The stock was sold at an average price of $222.80, for a total transaction of $6,786,488.00. Following the completion of the transaction, the executive vice president directly owned 2,687,660 shares of the company’s stock, valued at $598,810,648. The trade was a 1.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,766,118 shares of company stock valued at $399,450,353. 3.94% of the stock is owned by corporate insiders.

NVIDIA Price Performance NASDAQ:NVDA opened at $228.38 on Thursday. The company has a current ratio of 4.59, a quick ratio of 3.85 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $5.50 trillion, a P/E ratio of 28.87, a P/E/G ratio of 1.76 and a beta of 2.22. NVIDIA Corporation has a 12 month low of $164.27 and a 12 month high of $236.54. The business’s 50-day moving average is $217.76 and its 200 day moving average is $206.94.

NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.13. The company had revenue of $96.22 billion during the quarter, compared to analyst estimates of $92.27 billion. NVIDIA had a return on equity of 96.04% and a net margin of 63.66%.The firm’s revenue was up 105.9% on a year-over-year basis. During the same period in the prior year, the company earned $1.05 earnings per share. On average, equities research analysts forecast that NVIDIA Corporation will post 9.25 earnings per share for the current fiscal year.

NVIDIA Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Thursday, September 10th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. NVIDIA’s dividend payout ratio (DPR) is 12.64%.

NVIDIA declared that its Board of Directors has approved a share buyback plan on Monday, September 28th that allows the company to repurchase $150.00 billion in shares. This repurchase authorization allows the computer hardware maker to buy up to 2.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

Key Stories Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA authorized an additional $150 billion for share repurchases, raising total remaining authorization to approximately $235 billion through fiscal 2028. The move signals management’s confidence in the company’s cash generation and suggests it views the stock as attractively valued. Stock Market Today, Sept. 30: Nvidia Authorizes $150B Buyback, Lifting Total to $235B Positive Sentiment: The latest bullish case centers on sustained AI spending. NVIDIA’s data-center revenue reportedly surged 117% year over year to $89 billion, while management continues to forecast substantial growth despite the company’s enormous scale. Analysts cited valuation, hyperscaler capital expenditures and the company’s full-stack AI platform as potential upside drivers. Nvidia’s Demand Outlook Still Supports The Bull Case Positive Sentiment: Political and regulatory developments were also favorable. President Donald Trump reportedly supported industry self-regulation at a White House AI meeting attended by CEO Jensen Huang, reducing near-term concerns that stricter rules could slow AI deployment. NVIDIA’s new AI safety platform could further support demand for inference, monitoring and networking infrastructure. Nvidia Was the Big Winner of Trump’s AI Lunch, Here’s Why Positive Sentiment: NVIDIA’s reported agreement to acquire Hugging Face for nearly $13 billion would expand its reach into open-source models, developer tools, datasets and AI distribution. The company is also investing in AI infrastructure partners, reinforcing its broader ecosystem strategy beyond GPUs. Nvidia just spent nearly $13 billion on something other than GPUs Neutral Sentiment: Softer-than-expected inflation helped support growth-oriented technology shares by reducing immediate expectations for additional Federal Reserve rate increases. However, higher interest rates remain a key valuation risk for AI-linked stocks. Why is Nvidia stock rising on Wednesday? Negative Sentiment: Risks remain around an AI spending slowdown, particularly if hyperscalers reduce capital expenditures. DeepSeek’s work with Huawei on software for alternative AI chips could also challenge NVIDIA’s software moat, while rising memory and networking costs may pressure gross margins. Investor Michael Burry’s reported bearish options position adds to skepticism, although it has not changed the company’s fundamental outlook. If AI Capex Cracks, Nvidia Could Feel It Before Meta Does About NVIDIA (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

See Also Five stocks we like better than NVIDIA Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

Tortoise Investment Management LLC boosted its stake in NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 26.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 11,950 shares of the computer hardware maker’s stock after acquiring an additional 2,516 shares during the quarter. Tortoise Investment Management LLC’s holdings in NVIDIA were worth $2,391,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lifetime Wealth Management P.C. acquired a new stake in shares of NVIDIA in the fourth quarter valued at about $26,000. Longview Financial Advisors Inc. acquired a new position in shares of NVIDIA during the 1st quarter worth about $27,000. Langley Wealth Management LLC purchased a new position in NVIDIA in the 2nd quarter valued at about $34,000. Phillip James Consulting Co. purchased a new position in NVIDIA in the 1st quarter valued at about $40,000. Finally, Frankly Finances LLC acquired a new stake in NVIDIA in the 2nd quarter worth about $60,000. Hedge funds and other institutional investors own 65.27% of the company’s stock.

NVIDIA News Summary Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA authorized an additional $150 billion for share repurchases, raising total remaining authorization to approximately $235 billion through fiscal 2028. The move signals management’s confidence in the company’s cash generation and suggests it views the stock as attractively valued. Stock Market Today, Sept. 30: Nvidia Authorizes $150B Buyback, Lifting Total to $235B Positive Sentiment: The latest bullish case centers on sustained AI spending. NVIDIA’s data-center revenue reportedly surged 117% year over year to $89 billion, while management continues to forecast substantial growth despite the company’s enormous scale. Analysts cited valuation, hyperscaler capital expenditures and the company’s full-stack AI platform as potential upside drivers. Nvidia’s Demand Outlook Still Supports The Bull Case Positive Sentiment: Political and regulatory developments were also favorable. President Donald Trump reportedly supported industry self-regulation at a White House AI meeting attended by CEO Jensen Huang, reducing near-term concerns that stricter rules could slow AI deployment. NVIDIA’s new AI safety platform could further support demand for inference, monitoring and networking infrastructure. Nvidia Was the Big Winner of Trump’s AI Lunch, Here’s Why Positive Sentiment: NVIDIA’s reported agreement to acquire Hugging Face for nearly $13 billion would expand its reach into open-source models, developer tools, datasets and AI distribution. The company is also investing in AI infrastructure partners, reinforcing its broader ecosystem strategy beyond GPUs. Nvidia just spent nearly $13 billion on something other than GPUs Neutral Sentiment: Softer-than-expected inflation helped support growth-oriented technology shares by reducing immediate expectations for additional Federal Reserve rate increases. However, higher interest rates remain a key valuation risk for AI-linked stocks. Why is Nvidia stock rising on Wednesday? Negative Sentiment: Risks remain around an AI spending slowdown, particularly if hyperscalers reduce capital expenditures. DeepSeek’s work with Huawei on software for alternative AI chips could also challenge NVIDIA’s software moat, while rising memory and networking costs may pressure gross margins. Investor Michael Burry’s reported bearish options position adds to skepticism, although it has not changed the company’s fundamental outlook. If AI Capex Cracks, Nvidia Could Feel It Before Meta Does Analysts Set New Price Targets NVDA has been the subject of several research reports. Royal Bank Of Canada boosted their price objective on NVIDIA from $300.00 to $330.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Jefferies Financial Group restated a “buy” rating on shares of NVIDIA in a research report on Wednesday, August 26th. Truist Financial lifted their price target on NVIDIA from $307.00 to $346.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Daiwa Securities Group dropped their price target on NVIDIA from $255.00 to $245.00 and set an “outperform” rating for the company in a research report on Thursday, September 17th. Finally, Morgan Stanley set a $300.00 price objective on NVIDIA and gave the company an “overweight” rating in a research note on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $324.14. Check Out Our Latest Report on NVIDIA

Insider Buying and Selling at NVIDIA In other news, EVP Timothy Teter sold 30,460 shares of the company’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the transaction, the executive vice president owned 2,687,660 shares of the company’s stock, valued at $598,810,648. This represents a 1.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Colette Kress sold 34,918 shares of the stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total value of $7,648,787.90. Following the transaction, the chief financial officer owned 765,103 shares of the company’s stock, valued at approximately $167,595,812.15. This represents a 4.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,766,118 shares of company stock worth $399,450,353 over the last quarter. 3.94% of the stock is currently owned by company insiders.

NVIDIA Stock Performance NASDAQ:NVDA opened at $228.38 on Thursday. The company’s 50-day moving average is $217.76 and its two-hundred day moving average is $206.94. NVIDIA Corporation has a 1-year low of $164.27 and a 1-year high of $236.54. The company has a debt-to-equity ratio of 0.14, a current ratio of 4.59 and a quick ratio of 3.85. The firm has a market capitalization of $5.50 trillion, a price-to-earnings ratio of 28.87, a PEG ratio of 1.76 and a beta of 2.22.

NVIDIA (NASDAQ:NVDA – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The computer hardware maker reported $2.22 EPS for the quarter, beating the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The firm had revenue of $96.22 billion for the quarter, compared to analyst estimates of $92.27 billion. During the same quarter in the previous year, the company earned $1.05 EPS. The business’s revenue for the quarter was up 105.9% compared to the same quarter last year. Analysts forecast that NVIDIA Corporation will post 9.25 EPS for the current year.

NVIDIA Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Thursday, September 10th will be given a $0.25 dividend. The ex-dividend date is Thursday, September 10th. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. NVIDIA’s payout ratio is currently 12.64%.

NVIDIA announced that its board has initiated a share repurchase plan on Monday, September 28th that authorizes the company to repurchase $150.00 billion in outstanding shares. This repurchase authorization authorizes the computer hardware maker to repurchase up to 2.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

NVIDIA Company Profile (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Recommended Stories Five stocks we like better than NVIDIA Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

UNIVEST FINANCIAL Corp boosted its position in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) by 4.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 330,307 shares of the computer hardware maker’s stock after acquiring an additional 14,092 shares during the quarter. NVIDIA accounts for approximately 3.2% of UNIVEST FINANCIAL Corp’s investment portfolio, making the stock its 8th biggest holding. UNIVEST FINANCIAL Corp’s holdings in NVIDIA were worth $66,091,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of NVDA. J. Stern & Co. LLP increased its position in NVIDIA by 13,709.1% during the fourth quarter. J. Stern & Co. LLP now owns 125,760,307 shares of the computer hardware maker’s stock worth $23,454,297,000 after buying an additional 124,849,603 shares during the last quarter. Amundi boosted its stake in shares of NVIDIA by 10.4% during the 1st quarter. Amundi now owns 133,768,018 shares of the computer hardware maker’s stock worth $23,329,141,000 after acquiring an additional 12,575,177 shares during the period. SEB Asset Management AB bought a new position in shares of NVIDIA during the 1st quarter worth approximately $1,692,807,000. Employees Provident Fund Board acquired a new position in shares of NVIDIA during the 4th quarter worth approximately $1,243,336,000. Finally, H&H International Investment LLC raised its stake in NVIDIA by 91.3% in the 1st quarter. H&H International Investment LLC now owns 13,843,775 shares of the computer hardware maker’s stock valued at $2,414,354,000 after acquiring an additional 6,606,675 shares during the period. Institutional investors own 65.27% of the company’s stock.

Key Stories Impacting NVIDIA Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: NVIDIA authorized an additional $150 billion for share repurchases, raising total remaining authorization to approximately $235 billion through fiscal 2028. The move signals management’s confidence in the company’s cash generation and suggests it views the stock as attractively valued. Stock Market Today, Sept. 30: Nvidia Authorizes $150B Buyback, Lifting Total to $235B Positive Sentiment: The latest bullish case centers on sustained AI spending. NVIDIA’s data-center revenue reportedly surged 117% year over year to $89 billion, while management continues to forecast substantial growth despite the company’s enormous scale. Analysts cited valuation, hyperscaler capital expenditures and the company’s full-stack AI platform as potential upside drivers. Nvidia’s Demand Outlook Still Supports The Bull Case Positive Sentiment: Political and regulatory developments were also favorable. President Donald Trump reportedly supported industry self-regulation at a White House AI meeting attended by CEO Jensen Huang, reducing near-term concerns that stricter rules could slow AI deployment. NVIDIA’s new AI safety platform could further support demand for inference, monitoring and networking infrastructure. Nvidia Was the Big Winner of Trump’s AI Lunch, Here’s Why Positive Sentiment: NVIDIA’s reported agreement to acquire Hugging Face for nearly $13 billion would expand its reach into open-source models, developer tools, datasets and AI distribution. The company is also investing in AI infrastructure partners, reinforcing its broader ecosystem strategy beyond GPUs. Nvidia just spent nearly $13 billion on something other than GPUs Neutral Sentiment: Softer-than-expected inflation helped support growth-oriented technology shares by reducing immediate expectations for additional Federal Reserve rate increases. However, higher interest rates remain a key valuation risk for AI-linked stocks. Why is Nvidia stock rising on Wednesday? Negative Sentiment: Risks remain around an AI spending slowdown, particularly if hyperscalers reduce capital expenditures. DeepSeek’s work with Huawei on software for alternative AI chips could also challenge NVIDIA’s software moat, while rising memory and networking costs may pressure gross margins. Investor Michael Burry’s reported bearish options position adds to skepticism, although it has not changed the company’s fundamental outlook. If AI Capex Cracks, Nvidia Could Feel It Before Meta Does Insider Buying and Selling In other news, CFO Colette Kress sold 34,918 shares of the company’s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $219.05, for a total transaction of $7,648,787.90. Following the completion of the sale, the chief financial officer directly owned 765,103 shares in the company, valued at approximately $167,595,812.15. This represents a 4.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Timothy S. Teter sold 30,460 shares of the firm’s stock in a transaction on Monday, September 21st. The stock was sold at an average price of $222.80, for a total value of $6,786,488.00. Following the completion of the transaction, the executive vice president owned 2,687,660 shares in the company, valued at $598,810,648. The trade was a 1.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,766,118 shares of company stock valued at $399,450,353 over the last 90 days. 3.94% of the stock is owned by corporate insiders. NVIDIA Trading Up 0.5% NVDA stock opened at $228.38 on Thursday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.85 and a current ratio of 4.59. The company’s 50-day simple moving average is $217.76 and its 200 day simple moving average is $206.94. NVIDIA Corporation has a 52 week low of $164.27 and a 52 week high of $236.54. The company has a market capitalization of $5.50 trillion, a PE ratio of 28.87, a price-to-earnings-growth ratio of 1.76 and a beta of 2.22.

NVIDIA (NASDAQ:NVDA – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The computer hardware maker reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.13. NVIDIA had a net margin of 63.66% and a return on equity of 96.04%. The business had revenue of $96.22 billion during the quarter, compared to analysts’ expectations of $92.27 billion. During the same quarter in the previous year, the company earned $1.05 EPS. The business’s revenue was up 105.9% on a year-over-year basis. As a group, sell-side analysts anticipate that NVIDIA Corporation will post 9.25 earnings per share for the current year.

NVIDIA declared that its Board of Directors has approved a stock repurchase plan on Monday, September 28th that permits the company to repurchase $150.00 billion in shares. This repurchase authorization permits the computer hardware maker to purchase up to 2.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.

NVIDIA Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Thursday, September 10th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Thursday, September 10th. NVIDIA’s payout ratio is 12.64%.

Wall Street Analyst Weigh In NVDA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of NVIDIA in a report on Monday, August 31st. Weiss Ratings restated a “buy (b)” rating on shares of NVIDIA in a research note on Wednesday, July 8th. Stifel Nicolaus set a $315.00 target price on shares of NVIDIA in a report on Thursday, August 27th. Mizuho set a $315.00 price target on shares of NVIDIA and gave the company an “outperform” rating in a research note on Thursday, August 27th. Finally, DZ Bank restated a “buy” rating on shares of NVIDIA in a research report on Wednesday, August 26th. Four research analysts have rated the stock with a Strong Buy rating, fifty have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $324.14.

Check Out Our Latest Report on NVDA

NVIDIA Profile (Free Report)

NVIDIA Corporation is a technology company that designs accelerated computing platforms, graphics processing units (GPUs), central processing units (CPUs), networking products and related software. Its technologies are used in artificial intelligence, data centers, scientific and technical computing, gaming, professional visualization, automotive systems and robotics.

The company’s products include GeForce GPUs and gaming software, data center computing platforms, networking solutions, and enterprise software for AI development and deployment.

Featured Articles Five stocks we like better than NVIDIA Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors? O’Reilly Automotive’s Stock Slump Hides a Stronger Business McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

Nvidia just unlocked nearly $100 billion in buyback firepower while demand for its chips outstrips supply through 2028, and the valuation tells a story most investors are reading backwards.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) just expanded its capital return program, adding another data point to its long-term investment case.

My thesis is simple. Every AI lab, cloud provider, and government needs the machinery NVIDIA makes, and it can’t build enough of it. Management said on the August call that “NVIDIA Compute is fully utilized across every cloud we serve,” and it expects supply to remain a bottleneck at least through the end of fiscal year 2028. A business sold out for years carries unusual revenue visibility.

Buyback Firepower Signals Management Confidence The board added $80.0 billion to the repurchase authorization in May 2026, leaving about $99.0 billion available at the end of Q2 FY2027. That quarter, NVIDIA returned a record $26 billion: $20 billion in buybacks and $6 billion in dividends. Against a plan to return 50% or more of free cash flow, it returned 60% year to date, and management said it intends to “increase and return excess free cash flow net of strategic uses.” The quarterly dividend also rose from $0.01 to $0.25 per share. Every share retired with internally generated cash gives remaining shareholders a bigger claim on future profits.

Three Numbers Driving NVIDIA’s Momentum Growth is accelerating. Q2 revenue hit $96.22 billion, up 105.85% year over year, the fourth consecutive quarter of accelerating growth. Guidance calls for $108.0 billion next quarter, with preliminary fiscal 2028 growth of about 70%.

Each generation makes more. Revenue per gigawatt rose from $18 billion for Hopper to $25 billion for Blackwell and $40 billion for Vera Rubin, now in full production.

The balance sheet is a strong. Debt to equity is at 0.0726, interest coverage at 503.4x, and return on invested capital near 92.2%. Q2 EPS of $2.22 topped the $2.09 consensus, the 5th consecutive beat.

How NVIDIA Stacks Up Against AMD and Broadcom Advanced Micro Devices (NASDAQ:AMD) trades near 40 times forward earnings versus NVIDIA’s 25, with a trailing operating margin of 17.2% against NVIDIA’s 66.2%. AMD carries a higher valuation alongside lower profitability.

Broadcom (NASDAQ:AVGO) looks cheaper at about 19 times forward earnings and yields 0.74%. Yet its return on equity of 44.3% trails NVIDIA’s 117.2%, and its latest quarterly revenue growth of 85.5% falls behind NVIDIA’s 105.9%. NVIDIA’s modest valuation premium comes with faster growth and higher returns.

Risk I Track Every Quarter Supply obligations reached $279.0 billion, mostly memory for Vera Rubin, and guarantee obligations for partners are capped at $108.5 billion. Days sales outstanding stretched to 60 days from 45. A pause in AI spending could make those commitments hurt, and the price to free cash flow of 57 leaves little margin.

Guidance already excludes China data center compute revenue. Balancing that risk, top-five hyperscaler capex is expected to reach nearly $800 billion in 2026 and $1.3 trillion in 2027. Somebody has to power, cool, and network all that spending. We rounded up seven suppliers riding the same wave in a free AI infrastructure report.

Catalysts Ahead of the November Report Vera Rubin should make up about 20% of data center revenue in Q3, and the next earnings report lands November 17. Keep an eye on whether Vera Rubin’s ramp and continued buybacks keep pace with management’s free cash flow return targets.

Contact [email protected] for any questions or corrections.

watch now

Walmart is aiming to make it as easy as possible for its customers to find exactly what they want.

The retailer is leveraging three new tools tied to its digital shelf labels for both customers and store associates to better find products. It's the latest part of the company's push to modernize its technology and incorporate artificial intelligence into its business.

"We are people-led, tech-powered," said Greg Cathey, Walmart's senior vice president of digital transformation. "But the way we look at it is AI as a way to help associates do their job and free up time to allow them to invest in what they love to do most, which is spend more time with customers and their fellow associates."

The new feature for shoppers, called Shop to Light, allows customers to find specific products on the Walmart app, navigate to the correct aisle in the store and then flash the digital shelf label of the product to locate it. The retailer is now incorporating it widely following a pilot program.

That tool is also paired with Pick to Light and Stock to Light, which use the same capabilities to help store associates pick items for digital orders and stock products. All three features will be rolled out to stores companywide by the holiday season, Cathey said.

"This is a use case that customers have asked us for, associates have asked us for," Cathey said. "It gives them time back, and I think if you look at a lot of what we're trying to do, it's all around convenience and being able to help associates and customers free up that time to invest it where they want."

The rollout comes as convenience and speed — particularly in the delivery and pickup segments — have become critical pieces of Walmart's efforts to increase sales. While Walmart's business has grown steadily, and its e-commerce sales continue to soar, investor concerns about its comparable sales and revenue outlook weighed on its stock after its most recent earnings report in August.

Walmart stores carry roughly 120,000 items. Cathey said it's a priority for the company to provide that large range of products while making it easier for customers to locate precise items.

While the company does not publicly share any financial aspects of the program, Cathey said the new features at pilot stores allow associates and customers to have more time while shopping and stocking. The Shop to Light feature has already seen 5 million flashes from customers since it began rolling out to limited locations this summer.

He said these new features will be especially important as the retailer heads into the busy holiday season, and the company views them as "a big win" for time savings.

Walmart began using digital shelf labels, as opposed to paper labels, to allow automatic and systemwide price changes to be rolled out at once. The company currently has more than 4,300 stores with digital shelf labels, and expects them to be installed across the chain by the end of the year, according to Walmart.

He added that the label prices are changed overnight, when customers aren't in the store, and the system has human oversight as well to ensure it has "robust governance" and doesn't make mistakes. Currently, roughly 90% of the sections within the store have digital shelf labels, he said.

"We don't look at it as technology for technology's sake," Cathey said. "So we always have a human in the loop, and we're very focused on human judgment and their ability to make decisions."

A broader technology pushWalmart has been investing in its technology to modernize the business on both the consumer-facing side and in internal operations.

It's rolled out an AI agent to help customers with shopping, automated its supply chain, invested in radio frequency identification tags and set the stage for agentic commerce as it embraces AI. It's also spent billions on modernizing its store locations.

On Walmart's most recent earnings call, its CEO, John Furner, said the company is seeing significant returns on its technology strategies, including its investments in AI.

"We believe AI will improve nearly every part of our business by making shopping better, and our associates' work easier," he said.

Still, digital shelf labels and the company's AI push have sparked backlash. They have raised concerns about dynamic pricing and fears that digital labels could lead to price surges or privacy issues with collecting shopping data from customers.

But in an open letter last week, Furner said the company is continuing to "price the product, not the person," adding the retailer does not plan to use customer information to set prices.

"Your income, shopping history, urgency or what we think you could pay won't change the price," Furner wrote.

Cathey, who's been in his position for nearly a year, said his biggest priority when taking over the role was to focus on accelerating the speed of the technology that Walmart uses while keeping human oversight.

Several state legislatures, including New Jersey, have passed measures to restrict digital shelf labels over pricing concerns. Walmart said it has the feature in all of its stores in New Jersey.

Walmart in a statement called the policy an "overreaction, as digital shelf labels are not a tool for surveillance pricing and are simply a modern way to display prices."

Walmart has also invested in drone delivery – which has come under similar scrutiny over privacy concerns – to deliver products to customers in as fast as 30 minutes. That delivery option is available in select states, including Texas and Florida.

Ultimately, Cathey said the new digital shelf label features are all part of the company's bigger goal to ensure that store associates have more time to help meet the individual needs of customers.

And while investors debate whether physical retail or e-commerce is more important to the company's business, Cathey said the new features show that both go hand in hand.

"It's not one or the other anymore. It's both," he said. "We don't look at it as a store or an e-commerce fulfillment. They're actually one and the same."

Citi, Barclays, and Wells Fargo all lifted their HPE price targets after Networking Investor Day, yet the three firms land in very different places on whether the stock's explosive run has already consumed the upside.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Three Wall Street firms raised their price targets on Hewlett Packard Enterprise (NYSE:HPE | HPE Price Prediction) after its Networking Investor Day.

Citi moved its target to $92 from $76, Barclays to $83 from $79, and Wells Fargo to $63 from $54. None of the three changed its rating.

All three point to networking as HPE’s main growth engine, but they still disagree on how much of that upside the stock already prices in.

Ticker Company Firm Action Old Rating New Rating Old Target New Target HPE Hewlett Packard Enterprise Citi Price Target Raised Buy Buy $76 $92 HPE Hewlett Packard Enterprise Barclays Price Target Raised Overweight Overweight $79 $83 HPE Hewlett Packard Enterprise Wells Fargo Price Target Raised Equal Weight Equal Weight $54 $63 Analysts Agree Networking Now Drives the Story Barclays said HPE raised its fiscal 2027 networking outlook to high-teens to low-20s percent growth. At its September earnings call, the company had guided to 14% to 17%, and that figure left out the Helios platform from Advanced Micro Devices (NASDAQ:AMD). Barclays now says HPE sees Helios as an over $1B networking opportunity over the next two years.

Citi said the near-term financial update surprised investors and showed “strong” confidence in sustained growth over the longer term. The firm called the company’s messaging “incrementally bullish” for the shares.

Wells Fargo, taking a more measured view, cited a positive strategy overview and a higher FY27 outlook, and it found the Juniper integration better than expected. It added that performance on winning market share will be the focus.

HPE Snapshot: A Record Quarter Set the Stage Third-quarter fiscal 2026 revenue reached $12.21B, up 32.7% from a year earlier. Non-GAAP EPS of $1.11 beat the $0.93 consensus, making it the fifth straight quarterly EPS beat. Networking revenue rose 74.9% to $2.89B, and routing climbed 270%.

Orders for HPE’s networks for AI hit a quarterly record of $700 million. Juniper synergies remain on track for $600 million in annual run-rate savings by the end of FY28.

Why These Target Hikes Matter Now Hewlett Packard Enterprise stock trades at $63.71. That is up 168.23% year to date and 22.24% over the past month. The price already sits just above Wells Fargo’s new target, which helps explain why that firm still rates the shares Equal Weight.

Earnings estimates are rising along with the price. Consensus FY27 EPS now stands at $4.5974, compared with $4.1063 30 days ago. Analysts made 15 up revisions in that period and zero down ones.

What It Means for Your Portfolio A stronger networking outlook supports HPE’s growth case for long-term investors, though the stock’s sharp run-up raises the bar for performance. Shortages of DDR5 memory and NAND flash continued to restrict the conversion of demand into revenue. The company also lists trade policy and Juniper integration as risks.

All that AI-driven networking demand has to be powered and cooled by someone, and the suppliers behind the data-center expansion rarely get the attention the chipmakers do. We featured seven of them in a free report you can grab here.

Income-focused investors get a modest dividend yield of 0.94%. HPE also plans to return at least 75% of fourth-quarter free cash flow to shareholders.

The next checkpoint is the fiscal fourth-quarter report. HPE has guided for revenue of $13.9B to $14.8B and non-GAAP EPS of $1.20 to $1.30. Investors should also keep an eye on Helios ordering, which management expects to open later in the calendar year.

Contact [email protected] for any questions or corrections.

Hormel Foods has raised its dividend for 60 straight years, but something just happened on the earnings statement that has never happened before in two decades of records, and it raises a serious question about whether that streak has a…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Hormel Foods (NYSE:HRL | HRL Price Prediction) has raised its dividend for 60 consecutive years, a record that puts it on nearly every retiree’s short list. Its own guidance now tells a harder story: Hormel expects fiscal 2026 GAAP diluted EPS of $1.06 to $1.12, below its $1.17 annualized dividend. A high yield is only as good as the company’s ability to keep paying it, and that ability is under real strain.

Quick test: a dividend becomes unsustainable when earnings and free cash flow stop covering it and the company leans on cash reserves or debt to keep the checks going out.

Hormel Foods (HRL): A 5.9% Yield Built on a Falling Share Price At $19.97, Hormel yields 5.89%. For a low-volatility staple behind SPAM, Skippy, Planters and Jennie-O, with a beta of 0.315, that looks like a sleep-at-night income stream.

Look at where the yield came from. The quarterly dividend rose from $0.245 in 2021 to $0.2925 today, and the latest raise, from $0.29, was roughly 1%. Over the same stretch the shares fell 43.11% across five years, 15% over the past year and 7.42% in the past month alone. The yield expanded mainly because the price collapsed while dividend growth slowed to a crawl. This is a classic trap setup.

A Payout Line Hormel Had Not Crossed in Two Decades Hormel is an ordinary corporate, so earnings per share and net income are the proper metrics for coverage. In fiscal 2025, Hormel paid $633.2 million in dividends against net income of $477.8 million. In annual records going back to fiscal 2006, that was the first year dividends paid exceeded net income. Net income fell 40.6% that year.

Fiscal 2026 extends the problem. GAAP EPS guidance was cut to $1.06 to $1.12 from $1.28 to $1.37, and the original range was $1.29 to $1.39. Trailing diluted EPS is just $0.62. The damage traces to a $56M loss on the Brazil sale, a $48.2M impairment on an Indonesia stake and a $37.5M antitrust settlement.

Bulls will point to adjusted EPS guidance of $1.45 to $1.51, which does cover the dividend. Fair enough, but the cushion is thin, and one-time charges that repeat two years running deserve a skeptical eye.

Cash Flow Coverage Has Been Spotty Fiscal 2025 operating cash flow dropped 33.27% to $845.3 million while capex rose 21.24% to $310.9 million. Set capex and the $633.2 million dividend bill side by side, and together they exceeded the cash the business produced. Individual quarters were worse: in the quarter ending April 2025, operating cash flow of $56.4 million trailed dividends of $159.2 million.

The latest quarter improved. Operating cash flow rose 53.54% to $240.6 million against capex of $68.2 million and dividends of $161.0 million, which management credited to better inventory and working-capital management. One strong quarter helps. It does not yet prove a trend.

Balance Sheet Is Steady, but a Bill Is Coming Due Total debt was $2.855 billion at the end of July, essentially flat with $2.857 billion at fiscal 2025 year-end. The longer view is less comforting: debt stood at $250 million in fiscal 2019. Short-term debt jumped to $505.6 million from $6.6 million, signaling a maturity approaching, against cash of $839.6 million. Management called it “a sound financial position with ample liquidity and a conservative balance sheet.” That is true today, but refinancing or paying down that note competes with the dividend for the same cash.

Why a 60-Year Streak Cuts Both Ways On the August call, management said, “We remain committed to the dividend and are proud to have reached our 392nd consecutive quarterly payout.” CEO-elect John Ghingo added that “the dividend continues to be very important to us.”

That institutional pressure is real, and it brings down the odds of an outright near-term cut. It also explains the pattern: token raises, payouts held while earnings slide. A payout kept intact amid clear strain signals trouble rather than safety. The stress is visible: third-quarter revenue of $2.96B fell 2.4% and missed expectations, net income dropped 67.58%, and Ghingo said “the consumer environment right now really is not improving.” Leadership is also in transition, with an interim CEO and interim CFO on that call.

What Has to Go Right, and the One Number to Watch The path to safety exists. Foodservice posted its 12th consecutive quarter of organic sales growth, adjusted operating margin expanded to 9.0% from 8.4%, and management expects lower pork costs to flow through in future quarters, with a 53rd week in fiscal 2027 adding a boost. At 13x forward earnings, the market is partly pricing that recovery in. If the charges stop and cash flow holds at third-quarter levels, coverage repairs itself.

The verifiable test: when Hormel issues fiscal 2027 guidance, check whether the GAAP EPS range tops $1.17. If it does, the streak has breathing room. If it does not, Hormel faces a third straight year of paying more than it earns on a GAAP basis, and the risk rises sharply.

Dividend cuts rarely arrive alone; the stock usually falls with them. Hormel’s yield is fat because the stock has drop, and a 60-year streak can make a board stubborn right up to the point it cannot. The thesis rests on coverage.

Contact [email protected] for any questions or corrections.

RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 Viti-Up-1 and Viti-Up-2 studies show that among patients continuing RINVOQ, the proportions who achieved facial (F-VASI 75) and total body (T-VASI 50) repigmentation continued to increase through week 76 Findings from a phototherapy substudy show numerically higher responses with RINVOQ in combination with narrowband ultraviolet B (NB-UVB) phototherapy than with RINVOQ alone Data are being shared in a late-breaking oral presentation at the 2026 European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria , /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced late-breaking results from the ongoing Phase 3 Viti-Up-1 and Viti-Up-2 studies of RINVOQ® (upadacitinib; 15 mg once daily) in non-segmental vitiligo (NSV), showing continued facial and total body repigmentation through week 76.

Presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress, data also include week-28 findings from a phototherapy substudy, in which treatment groups receiving RINVOQ plus whole-body narrowband ultraviolet B (NB-UVB) phototherapy showed numerically higher repigmentation responses than groups receiving RINVOQ alone.

"Vitiligo is a chronic, unpredictable disease that can affect skin across the body, underscoring the need for systemic treatment options that go beyond addressing individual areas," said Kori Wallace, M.D., Ph.D., vice president, global head of immunology clinical development, AbbVie. "These late-breaking data support that RINVOQ can provide meaningful long-term repigmentation for patients with vitiligo and provide an early foundation for further research into its combination with NB-UVB phototherapy."

Continued Repigmentation with RINVOQ Through 76 Weeks

Following the 48-week placebo-controlled period (Period A) in the ongoing Phase 3 Viti-Up-1 and Viti-Up-2 studies, patients either entered an open-label extension (OLE) and received RINVOQ 15 mg once daily or entered a phototherapy substudy.

In patients who continued on RINVOQ 15 mg once daily in the OLE, proportions of patients achieving F-VASI 75 and T-VASI 50 continued to increase from week 48 through week 76. Results for F-VASI 75 and T-VASI 50 in both studies are shown in the tables below.

Viti-Up-1 & Viti-Up-2 Observed-Case Analyses

Viti-Up-1

Viti-Up-2

RINVOQ 15 mg
once daily at Week 48

(N=130)

Continued
RINVOQ 15 mg
once daily at Week 76

(N=127)

RINVOQ 15 mg
once daily at Week 48

 (N=145)

Continued
RINVOQ 15 mg
once daily at Week 76

(N=137)

F-VASI 75*          

33.1 %

55.1 %

27.6 %

47.4 %

T-VASI 50*

29.2 %

42.5 %

26.2 %

40.1 %

*F-VASI 75 = ≥75% reduction from baseline in Facial Vitiligo Area Scoring Index; T-VASI 50 = ≥50% reduction from baseline in Total Vitiligo Area Scoring Index

Findings With RINVOQ and NB-UVB Phototherapy

Following completion of Period A in Viti-Up-1 or Viti-Up-2, 84 adults who failed to achieve T-VASI 90 at week 48 and met additional eligibility criteria were re-randomized to receive RINVOQ 15 mg once daily alone or in combination with whole-body NB-UVB phototherapy twice weekly for 28 weeks.

All groups showed improvement in facial and total body repigmentation from baseline, with numerically higher response rates observed in the RINVOQ + NB-UVB phototherapy combination groups than in the RINVOQ monotherapy groups. Detailed F-VASI 75 and T-VASI 50 results are shown in the table below.

Efficacy at Week 28 (NRI*)

Viti-Up-1/2 Period A Treatment (Tx): Placebo

Phototherapy Substudy Tx:     

     RINVOQ     
(N=15)

     RINVOQ + NB-UVB     
(N=15)

F-VASI 75

40.0 %

46.7 %

T-VASI 50

20.0 %

33.3 %

Viti-Up-1/2 Period A Tx: RINVOQ

Phototherapy Substudy Tx:

RINVOQ
(N=27)

RINVOQ + NB-UVB
(N=27)

F-VASI 75

37.0 %

59.3 %

T-VASI 50

33.3 %

63.0 %

*NRI = Non-responder Imputation

"These findings are important for physicians treating people with vitiligo because they extend our understanding of repigmentation with continued RINVOQ treatment and provide the first data on combining NB-UVB with an approved systemic JAK inhibitor," said Julien Seneschal, M.D., Ph.D., professor of dermatology at the National Reference Center for Rare Skin Diseases, University of Bordeaux, France. "This research opens an important path for further investigation into how combination approaches could evolve to support patient care in non-segmental vitiligo."

Safety results for week 76 in Viti-Up-1 and Viti-Up-2 and for week 28 in the phototherapy substudy were consistent with the known safety profile of upadacitinib and with the profile observed during the 48-week Period A; no new safety signals were reported.

RINVOQ is the first and only systemic medication approved in the European Union for the treatment of adult and adolescent patients 12 years and older with NSV who are candidates for systemic therapy. The approval was based on results from the Phase 3 Viti-Up clinical program at week 48 versus placebo. The use of RINVOQ in non-segmental vitiligo is under regulatory review by the U.S. FDA.

About Viti-Up Clinical Trials 
Viti-Up (upadacitinib M19-044) consists of two ongoing replicate Phase 3 studies (Viti-Up-1 and Viti-Up-2) conducted under a single protocol, with independent randomization, investigative sites, data collection, analysis and reporting for each study. The trials evaluate the efficacy, safety and tolerability of upadacitinib in adult and adolescent patients (ages 12 and older) with non-segmental vitiligo (NSV) who are candidates for systemic therapy. In Period A of both studies, participants were randomized in a 2:1 ratio to receive either upadacitinib 15 mg once daily or placebo for 48 weeks. Participants who completed Period A were eligible to enter Period B, an 112-week open-label extension in which all patients, including those initially randomized to placebo, received upadacitinib 15-mg once daily; together, Periods A and B span 160 weeks. The two studies randomized 614 participants with NSV across 90 sites worldwide. Following completion of Period A in Viti-Up-1 or Viti-Up-2, 84 adults who failed to achieve T-VASI 90 at week 48 and met additional eligibility criteria were re-randomized to receive RINVOQ 15 mg once daily alone or in combination with whole-body NB-UVB phototherapy twice weekly for 28 weeks.

More information on these trials can be found at www.clinicaltrials.gov (NCT06118411).

About RINVOQ® (upadacitinib)
Discovered and developed by AbbVie scientists, RINVOQ is a selective and reversible JAK inhibitor that is being studied in several immune-mediated inflammatory diseases.1,2 In human cellular assays, RINVOQ preferentially inhibits signaling by JAK1 or JAK 1/3 with functional selectivity over cytokine receptors that signal via pairs of JAK2.1

Upadacitinib (RINVOQ) is being studied in Phase 3 clinical trials for hidradenitis suppurativa, Takayasu arteritis and systemic lupus erythematosus and in pediatric studies for systemic juvenile idiopathic arthritis, atopic dermatitis, ulcerative colitis and Crohn's disease.

EU Indications and Important Safety Information about RINVOQ® (upadacitinib)1

Indications

Rheumatoid arthritis

RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate.

Psoriatic arthritis

RINVOQ is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate.

Polyarticular juvenile idiopathic arthritis

RINVOQ is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) [polyarticular rheumatoid factor positive {RF+} or negative {RF-}, extended oligoarticular], in patients 2 years of age and older who have responded inadequately to, or who are intolerant to one or more DMARDs. RINVOQ may be used as monotherapy or in combination with methotrexate.

Axial spondyloarthritis

Non-radiographic axial spondyloarthritis (nr-axSpA)

RINVOQ is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).

Ankylosing spondylitis (AS, radiographic axial spondyloarthritis)

RINVOQ is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy.

Giant cell arteritis

RINVOQ is indicated for the treatment of giant cell arteritis (GCA) in adult patients.

Atopic dermatitis

RINVOQ is indicated for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents 12 years and older who are candidates for systemic therapy.

Alopecia areata

RINVOQ is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

Vitiligo

RINVOQ is indicated for the treatment of non-segmental vitiligo in adults and adolescents 12 years and older who are candidates for systemic therapy.

Ulcerative colitis

RINVOQ is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Crohn's disease

RINVOQ is indicated for the treatment of adult patients with moderately to severely active Crohn's disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Important Safety Information

Contraindications
RINVOQ is contraindicated in patients hypersensitive to the active substance or to any of the excipients, in patients with active tuberculosis (TB) or active serious infections, in patients with severe hepatic impairment, and during pregnancy.

Special warnings and precautions for use
RINVOQ should only be used if no suitable treatment alternatives are available in patients:
- 65 years of age and older;
- patients with history of atherosclerotic cardiovascular (CV) disease or other CV risk factors (such as current or past long-time smokers);
- patients with malignancy risk factors (e.g. current malignancy or history of malignancy)

Use in patients 65 years of age and older
Considering the increased risk of MACE, malignancies, serious infections, and all-cause mortality in patients ≥65 years of age, as observed in a large randomised study of tofacitinib (another Janus Kinase (JAK) inhibitor), RINVOQ should only be used in these patients if no suitable treatment alternatives are available. In patients ≥65 years of age, there is an increased risk of adverse reactions with RINVOQ 30 mg once daily. Consequently, the recommended dose for long-term use in this patient population is 15 mg once daily.

Immunosuppressive medicinal products
Use in combination with other potent immunosuppressants is not recommended.

Serious infections
Serious and sometimes fatal infections have been reported in patients receiving RINVOQ. The most frequent serious infections reported included pneumonia and cellulitis. Cases of bacterial meningitis and sepsis have been reported with RINVOQ. Among opportunistic infections, TB, multidermatomal herpes zoster, oral/esophageal candidiasis, and cryptococcosis have been reported. RINVOQ should not be initiated in patients with an active, serious infection, including localized infections. RINVOQ should be interrupted if a patient develops a serious or opportunistic infection until the infection is controlled. A higher rate of serious infections was observed with RINVOQ 30 mg compared to 15 mg. As there is a higher incidence of infections in the elderly and patients with diabetes in general, caution should be used when treating these populations. In patients ≥65 years of age, RINVOQ should only be used if no suitable treatment alternatives are available.

Tuberculosis
Patients should be screened for TB before starting RINVOQ. RINVOQ should not be given to patients with active TB. Anti-TB therapy may be appropriate for select patients in consultation with a physician with expertise in the treatment of TB. Patients should be monitored for the development of signs and symptoms of TB.

Viral reactivation
Viral reactivation, including cases of herpes zoster, was reported in clinical studies. The risk of herpes zoster appears to be higher in Japanese patients treated with RINVOQ. Consider interruption of RINVOQ if the patient develops herpes zoster until the episode resolves. Screening for viral hepatitis and monitoring for reactivation should occur before and during therapy. If hepatitis B virus DNA is detected, a liver specialist should be consulted.

Vaccination
The use of live, attenuated vaccines during or immediately prior to therapy is not recommended. It is recommended that patients be brought up to date with all immunizations, including prophylactic zoster vaccinations, prior to initiating RINVOQ, in agreement with current immunization guidelines.

Malignancy
Lymphoma and other malignancies have been reported in patients receiving JAK inhibitors, including RINVOQ. In a large randomised active‑controlled study of tofacitinib (another JAK inhibitor) in RA patients ≥50 years of age with ≥1 additional CV risk factor, a higher rate of malignancies, particularly lung cancer, lymphoma, and non-melanoma skin cancer (NMSC), was observed with tofacitinib compared to tumour necrosis factor (TNF) inhibitors. A higher rate of malignancies, including NMSC, was observed with RINVOQ 30 mg compared to 15 mg. Periodic skin examination is recommended for all patients, particularly those with risk factors for skin cancer. In patients ≥65 years of age, patients who are current or past long-time smokers, or patients with other malignancy risk factors (e.g., current malignancy or history of malignancy), RINVOQ should only be used if no suitable treatment alternatives are available.

Hematological abnormalities
Treatment should not be initiated, or should be temporarily interrupted, in patients with hematological abnormalities observed during routine patient management.

Gastrointestinal perforations
Events of diverticulitis and gastrointestinal perforations have been reported in clinical trials and from post marketing sources. RINVOQ should be used with caution in patients who may be at risk for gastrointestinal perforation (e.g., patients with diverticular disease, a history of diverticulitis, or who are taking non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or opioids. Patients with active Crohn's disease are at increased risk for developing intestinal perforation. Patients presenting with new onset abdominal signs and symptoms should be evaluated promptly for early identification of diverticulitis or gastrointestinal perforation.

Major adverse cardiovascular events
MACE were observed in clinical studies of RINVOQ. In a large randomised active-controlled study of tofacitinib (another JAK inhibitor) in RA patients ≥50 years of age with ≥1 additional CV risk factor, a higher rate of MACE, defined as CV death, non-fatal myocardial infarction and non-fatal stroke, was observed with tofacitinib compared to TNF inhibitors. Therefore, in patients ≥65 years of age, patients who are current or past long-time smokers, and patients with history of atherosclerotic CV disease or other CV risk factors, RINVOQ should only be used if no suitable treatment alternatives are available.

Lipids
RINVOQ treatment was associated with dose-dependent increases in lipid parameters, including total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol.

Hepatic transaminase elevations
Treatment with RINVOQ was associated with an increased incidence of liver enzyme elevation. Hepatic transaminases must be evaluated at baseline and thereafter according to routine patient management. If alanine transaminase (ALT) or aspartate transaminase (AST) increases are observed and drug-induced liver injury is suspected, RINVOQ should be interrupted until this diagnosis is excluded.

Venous thromboembolism
Events of deep venous thrombosis (DVT) and pulmonary embolism (PE) were observed in clinical trials for RINVOQ. In a large randomised active-controlled study of tofacitinib (another JAK inhibitor) in RA patients ≥50 years of age with ≥1 additional CV risk factor, a dose‑dependent higher rate of VTE including DVT and PE was observed with tofacitinib compared to TNF inhibitors. In patients with CV or malignancy risk factors, RINVOQ should only be used if no suitable treatment alternatives are available. In patients with known VTE risk factors other than CV or malignancy risk factors (e.g. previous VTE, patients undergoing major surgery, immobilisation, use of combined hormonal contraceptives or hormone replacement therapy, and inherited coagulation disorder), RINVOQ should be used with caution. Patients should be re-evaluated periodically to assess for changes in VTE risk. Promptly evaluate patients with signs and symptoms of VTE and discontinue RINVOQ in patients with suspected VTE.

Retinal vein occlusion
Retinal vein occlusion has been reported in patients treated with JAK inhibitors, including upadacitinib. Patients should be advised to promptly seek medical care in case they experience symptoms suggestive of retinal vein occlusion.

Hypersensitivity reactions
Serious hypersensitivity reactions such as anaphylaxis and angioedema have been reported in patients receiving RINVOQ. If a clinically significant hypersensitivity reaction occurs, discontinue RINVOQ and institute appropriate therapy.

Hypoglycemia in patients treated for diabetes
There have been reports of hypoglycemia following initiation of JAK inhibitors, including RINVOQ, in patients receiving medication for diabetes. Dose adjustment of anti-diabetic medication may be necessary in the event that hypoglycemia occurs.

Medication residue in stool
Reports of medication residue in stool or ostomy output have occurred in patients taking RINVOQ tablets. Most reports described anatomic (e.g., ileostomy, colostomy, intestinal resection) or functional gastrointestinal conditions with shortened gastrointestinal transit times. Patients should be instructed to contact their healthcare professional if medication residue is observed repeatedly. Patients should be clinically monitored, and alternative treatment should be considered if there is an inadequate therapeutic response.

Giant cell arteritis
RINVOQ monotherapy should not be used for the treatment of acute relapses as efficacy in this setting has not been established. Corticosteroids should be given according to medical judgement and practice guidelines.

Excipients with known effect
RINVOQ 1 mg/ml oral solution contains 0.3 mg sodium benzoate in each ml.

Adverse reactions
The most commonly reported adverse reactions in RA, PsA, and axSpA clinical trials (≥2% of patients in at least one of the indications) with RINVOQ 15 mg were upper respiratory tract infections, blood creatine phosphokinase (CPK) increased, ALT increased, bronchitis, nausea, neutropenia, cough, AST increased, and hypercholesterolemia. Overall, the safety profile observed in patients with psoriatic arthritis or active axial spondyloarthritis treated with RINVOQ 15 mg was consistent with the safety profile observed in patients with RA.

The most commonly reported adverse reactions in AD trials (≥2% of patients) with RINVOQ 15 mg or 30 mg were upper respiratory tract infection, acne, herpes simplex, headache, blood CPK increased, cough, folliculitis, abdominal pain, nausea, neutropenia, pyrexia, and influenza. Dose dependent increased risks of infection and herpes zoster were observed with RINVOQ. The safety profile for RINVOQ 15 mg and 30 mg in adolescents was similar to that in adults. With long-term exposure, skin papilloma was reported in adolescents in the RINVOQ 15 mg and 30 mg groups.

The most commonly reported adverse reactions in the UC and CD trials (≥3% of patients) with RINVOQ 45 mg, 30 mg or 15 mg were upper respiratory tract infection, pyrexia, blood CPK increased, anemia, headache, acne, herpes zoster, neutropenia, rash, pneumonia, hypercholesterolemia, bronchitis, AST increased, fatigue, folliculitis, ALT increased, herpes simplex, and influenza. The overall safety profile observed in patients with UC was generally consistent with that observed in patients with RA. Overall, the safety profile observed in patients with CD treated with RINVOQ was consistent with the known safety profile for RINVOQ.

Overall, the safety profile observed in patients with GCA treated with RINVOQ 15 mg was generally consistent with the known safety profile for RINVOQ.

Overall, the safety profile observed in paediatric patients with pJIA treated with RINVOQ was consistent with the known safety profile of RINVOQ.

The safety profile of RINVOQ 15 mg and 30 mg observed in patients with alopecia areata was generally consistent with the known safety profile in patients with atopic dermatitis.

The safety profile of RINVOQ 15 mg observed in patients with vitiligo was generally consistent with the known safety profile in patients with atopic dermatitis. A higher incidence of hypercholesterolemia was observed in patients with vitiligo treated with RINVOQ 15 mg compared to placebo.

The most common serious adverse reactions were serious infections.

The safety profile of RINVOQ with long term treatment was generally similar to the safety profile during the placebo-controlled period across indications.

RINVOQ is available in 15 mg, 30 mg, and 45 mg prolonged-release tablets and 1 mg/ml oral solution. RINVOQ tablets and RINVOQ oral solution are not bioequivalent. Refer to the Summary of Product Characteristics for posology and method of administration.

This is not a complete summary of all safety information.

See RINVOQ full Summary of Product Characteristics (SmPC) at http://www.ema.europa.eu 

Globally, prescribing information varies; refer to the individual country product label for complete information.

About AbbVie in Immunology
AbbVie is relentless in our pursuit to redefine the standard of care for patients living with immune-mediated conditions, with the goal of helping them live a life free from the limitations of their disease. For more than 20 years, AbbVie has led and helped shape the field of immunology through groundbreaking science and trusted medicines. Building on deep expertise across gastroenterology, rheumatology and dermatology, and other areas of high unmet need, we continue to invest in a broad and differentiated pipeline – spanning innovative modalities, novel mechanisms of action and next-generation approaches designed to conquer the complex biology underlying immune-mediated disease.

Today, more than 1 million patients worldwide are treated with AbbVie's immunology medicines, approved in more than 175 countries across 20+ immune-mediated diseases that impact adult and pediatric populations. As we work to strengthen our legacy and drive the next wave of innovation, we remain focused on delivering meaningful progress for patients and expanding access to our medicines. For more information, please visit www.abbvie.com/immunology.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2025 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

References

RINVOQ. Summary of product characteristics. AbbVie; 2026. Pipeline. AbbVie. 2026. Accessed September 8, 2026. https://www.abbvie.com/our-science/pipeline.html ALL-RNQD-260137

SOURCE AbbVie

Only a handful of companies have benefited more from the current artificial intelligence (AI) boom than Broadcom (AVGO -0.76%). Shares of the semiconductor giant are up 330% in the past three years, and Broadcom now sits as the world's ninth-most valuable company, with a market capitalization of $1.68 trillion (as of Sept. 28).

Broadcom has made plenty of millionaires through the years, but after its current run-up, has that ship sailed? If you have time on your side, I don't believe so.

Image source: Getty Images.

The math behind reaching $1 million from scratch Whether a stock is a millionaire maker depends largely on two things: how much you have to invest and how long you have to invest. If you have $500,000 to invest at once, reaching $1 million is much easier than if you needed $25,000 to grow 40-fold. The same goes for time. If you're trying to go from scratch to $1 million in a decade, you'll need much higher returns than someone with a 20-year horizon.

Investors are more likely to have time than a six-figure lump sum, so for our example, we'll assume a 20-year horizon. Here are different investment amounts and average annual return combinations that it would take to reach a million if you're starting from scratch:

Annual Investment (Monthly)Average Annual Returns$3,000 ($250)24.8%$6,000 ($500)19.1%$9,000 ($750)15.7%$12,000 ($1,000)13.3%$18,000 ($1,500)9.8% Data source: Table by author.

If you can invest $750 to $1,500 in Broadcom monthly, I see it as a millionaire maker. If you're starting from scratch and trying with just $250 monthly, it's a bit more far-fetched to happen in 20 years.

Premium Feature

Moneyball Superscore

90/100

Today's Change

(

-0.76

%) $

-2.68

Current Price

$

348.51

Riding a high, but built to last Broadcom's recent success is mostly due to its role in the AI ecosystem, supplying custom AI chips and networking equipment. In the third quarter (Q3), semiconductor revenue from AI jumped 221% year over year to $16.7 billion. In Q4, it expects it to jump 236% year over year to $21.7 billion. This continues an impressive run, with Broadcom's revenue and net income up 218% and 271%, respectively, over the past three years.

AVGO Revenue (Quarterly) data by YCharts

The current AI boom has Broadcom in a great place, but if you're investing with seven figures in mind, the business needs to be built to last. In Broadcom's case, it has done a good job building a hardware and software ecosystem that keeps business steady beyond the current hype.

AI aside, Broadcom's chips and wireless parts are used in everything from smartphones to broadband equipment to smart TVs. Right now, it has high customer concentration, with AI hyperscalers (companies that own major data centers) spending hundreds of billions to build out their data centers, but Broadcom's business is a huge part of the overall tech infrastructure.

Trading at 30 times its projected earnings over the next 12 months, Broadcom's stock is expensive. It's much cheaper than the 41 it traded at in June but still expensive enough that investors should be aware the stock could be vulnerable to a pullback. Still, if you're in it for the long haul, this shouldn't deter you.

 News Highlights:

HP OmniBook 5 combines vibrant OLED visuals, rich audio, and AI-enhanced capabilities to help consumers create, connect and be entertained wherever they goHP ProBook 4 equips growing businesses with AI-ready performance and portability to stay productive wherever work happens PALO ALTO, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Today, HP Inc. (NYSE: HPQ) announced the new HP OmniBook 5, a premium consumer Windows laptop designed for people who want more from their everyday device: more screen, more battery life, more connectivity and more freedom to create, connect and be entertained without compromise.

“Today's consumers expect technology that fits naturally into their lives – beautifully designed, easy to use, and powerful enough to support everything from collaboration and content creation to entertainment and everyday productivity,” said Samuel Chang, Senior Vice President and Division President, Consumer Personal Systems at HP Inc. “The new HP OmniBook 5 delivers exactly that, bringing together premium design and immersive experiences with a colorful OLED display in an incredibly portable package for work, study, and entertainment.”

Premium Experiences, Made Accessible
Consumers increasingly expect a PC that helps them stay productive, connected, and entertained without adding complexity to their lives. Whether streaming content, attending class, creating, collaborating, or staying connected with friends and family, they want premium experiences that fit their lifestyles, their budgets, and help prepare for what comes next. The HP OmniBook 5 was designed to deliver exactly that: bringing together thoughtful design, immersive entertainment, and everyday practicality in one accessible device.

Designed for students, young professionals and modern multitaskers, the device delivers the experiences people value most, from immersive entertainment to seamless connectivity, in a device built to fit naturally into everyday life:

Empowers productivity and creativity with AI-ready performance: Powered by up to an Intel® Core™ 7 processori with integrated NPU capabilitiesii, the HP OmniBook 5 helps users stay productive, communicate effectively and take advantage of the latest AI-ready experiences across work, school and personal projects.Adapts to life on the move with up to 42 hours of VPB (Local Video Playback) battery lifeiii and effortless mobility: Combining an ultra-thin 11.77 mm profile, lightweight 1.16 kg design, flexible 180° hinge, dual full-function USB-C®iv ports and HP's compact 65W USB Mini GaN chargerv, the HP OmniBook 5 is built to move effortlessly from campus to café, commute to couch and everywhere in between.Delivers rich entertainment experiences: Featuring up to a 2.5K OLEDvi touch display, 100% DCI-P3 color coverage, up to 620 nits brightnessvii, HP Eye Ease technology and up to a 90% screen-to-body ratio, the HP OmniBook 5 delivers vivid visuals and immersive entertainment wherever users go.Enhances seamless collaboration and connection: An FHD IR camera with Windows Hello facial recognition, dual microphones, Poly Studio-tuned audioviii and DTS:X Ultra help users show up clearly and confidently for classes, calls and everyday conversations.Expresses individuality through thoughtful design: Available in Smoke Silver, Starlit Blue, Peony Pink and Soft Honeydew, the HP OmniBook 5 combines a premium aluminum chassis, tone-on-tone keyboard and refined design details that help consumers choose a device that reflects their personal style. Premium Design, Built for Growing Businesses
HP is also bringing premium design and AI-ready performance to growing businesses with the HP ProBook 4. Purpose-built for SMBs and mobile professionals, the device delivers the design, mobility and performance growing businesses need without compromising on durability or value.

As HP’s thinnest business notebook,ix the HP ProBook 4 pairs a sleek 12mm thinx aluminum design with real portability, starting at just 2.6 lbs.,xi so it travels light without feeling delicate. The device comes in three finishes – Eclipse Gray, Atmospheric Blue, and Mist Silver – with a 14-inch 2.8K OLED displayxii bringing work to life with rich 100% DCI-P3 color and fluid 120Hz motion.

Powered by up to an Intel® Core™ 7 processori with up to 17 TOPS NPU AI accelerationxiii, up to 32 GB of memory and up to 1TB of storage, the HP ProBook 4keeps everyday productivity and AI-enhanced work moving. A 70Whr battery with HP Fast Charge,xiv along with MIL-STD durability,xv helps professionals work confidently.

Pricing and Availabilityxvi

The HP OmniBook 5 14 AI PC is expected to be available on HP.com and Best Buy in October for a starting price of $699.99.The HP ProBook 4 G2iS 14 AI PC is expected to be available on HP.com in November. Pricing will be announced closer to availability. About HP
HP Inc. (NYSE: HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 countries, HP delivers a wide range of innovative and sustainable devices, services, and subscriptions for personal computing, printing, 3D printing, hybrid work, gaming, and more. For more information, please visit http://www.hp.com.

i Multi-core is designed to improve performance of certain software products. Not all customers or software applications will necessarily benefit from use of this technology. Performance and clock frequency will vary depending on application workload and your hardware and software configurations. Intel's numbering is not a measurement of higher performance. Models with Intel® Core™ 7 processors planned to be available mid-October 2026.
ii Features and software that require a NPU may require may require software purchase, subscription or enablement by a software or platform provider, and third-party software may have specific configuration or compatibility requirements. Potential NPU inferencing performance varies by use, configuration, and other factors.
iii Battery life tested by HP using continuous FHD video playback, 1080p (1920x1080) resolution, 200 nits brightness, system audio level as image default, player audio level at 100%, played full-screen from local storage, headphone attached or through speaker (if no audio jack port), wireless on but not connected. Actual battery life will vary depending on configuration and maximum capacity will naturally decrease with time and usage.
iv Actual throughput may vary. USB Type-C® and USB-C® are trademarks of USB Implementers Forum. DisplayPort™ and the DisplayPort™ logo are trademarks owned by the Video Electronics Standards Association (VESA®) in the United States and other countries.
v Performance and compatibility may vary by device. Subject to change without notice. Compared to previous generation HP power adapters.
vi Features may require software or other third-party applications to provide the described functionality. Internet service required and not included.
vii All performance specifications represent the typical specifications provided by HP's component manufacturers; actual performance may vary either higher or lower. 2K OLED version with up to 300 nits brightness available at launch. 2.5K OLED version with up to 620 nits brightness planned to be available March 2027.
viii Features may require software or other third-party applications to provide the described functionality. Internet service required and not included.
ix Based on HP’s internal analysis of HP business notebook PCs with preinstalled encryption, authentication, malware protection and BIOS-level protection, passing MIL-STD testing, USB-C docking including power delivery, clamshell form factor, Intel U series or AMD Ryzen Pro processors, HDMI, and at least 2 USB 3.1 Gen 1 ports, optional WWAN in HP’s current commercial portfolio as of September 26. Claim based on the lowest maximum published z-height of the device. Actual dimensions may vary by configuration and manufacturing tolerances.
x Based on HP internal analysis of product specifications, including thickness comparisons among HP commercial notebook PCs available as of 08/03/2026. Dimensions are typical. Actual dimensions may vary by +/- 0.5 mm, and height may vary by configuration. Maximum height does not include rubber feet.
xi Actual weight will vary by configuration.
xii All performance specifications represent the typical specifications provided by HP's component manufacturers; actual performance may vary either higher or lower.
xiii Features and software that require an NPU may require software purchase, subscription or enablement by a software or platform provider, and third-party software may have specific configuration or compatibility requirements. Potential NPU inferencing performance varies by use, configuration, and other factors.
xiv Recharges your battery up to 50% within 45 minutes when the system is off or in standby mode. Power adapter minimum of 65 watts required for battery capacities 56Whr or less. Power adapter minimum of 100 watts required for battery capacities greater than 56Whr and less than 83Whr. Power adapter minimum of 120 watts required for battery capacities greater than 83Whr and less than 100Whr. After charging has reached 50% capacity, charging will return to normal. Charging time may vary +/-10% due to System tolerance.
xv MIL STD 810 testing is not intended to demonstrate fitness for U.S. Department of Defense contract requirements or for military use. Test results are not a guarantee of future performance under these test conditions. Any accidental damage requires an optional HP Accidental Damage Protection Care Pack.
xvi Pricing and availability subject to change without notice.

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6cc6624d-02b2-4cd7-8f82-b10d366e3c7c
https://www.globenewswire.com/NewsRoom/AttachmentNg/a91d96ae-e54c-49e6-8fd7-e63d5f2cf13b
https://www.globenewswire.com/NewsRoom/AttachmentNg/9a0c5ddc-2a6f-44da-abb7-6a9a712cf234

Key Takeaways CVX is expanding its Venezuelan footprint with more than $7 billion in planned investment over five years.E became operator of Junin-5, a 35-billion-barrel heavy-oil field targeting 400,000 barrels per day by 2030.TTE and HAL are renewing Venezuelan activity through energy cooperation and development agreements. Venezuela’s oil and gas industry is attracting renewed interest from international energy companies, creating a potentially important investment theme for the global energy sector. Fresh agreements involving major producers and oilfield service companies point to increasing efforts to develop the country’s enormous hydrocarbon resources.

The renewed focus on Venezuela comes as global oil markets face continued supply uncertainty. Crude oil remained above $90 per barrel on Thursday as investors weighed recovering Middle East supplies against ongoing U.S.-Iran negotiations. Uncertainty surrounding the Strait of Hormuz and OPEC+’s decision to maintain November output quotas could increase the strategic importance of Venezuela’s large oil resource base.

Several companies with Venezuelan exposure have delivered strong share price gains over the past year. Eni S.p.A. (E - Free Report) shares have advanced 55.4%, while TotalEnergies SE (TTE - Free Report) , Halliburton Company (HAL - Free Report) and Chevron Corporation (CVX - Free Report) have gained 43.3%, 29.3% and 31.5%, respectively.

How Energy Stocks Have Performed Over the Past Year
Image Source: Zacks Investment Research

The gains highlight the strong recent performance of these energy stocks, although their future performance will depend on company-specific operating results, oil prices and the execution of Venezuelan projects.

The emerging Venezuela opportunity is centered on four themes: higher investment in Venezuelan oil assets, production growth, development of heavy-oil resources and rising demand for oilfield services. For investors, these trends could create different forms of exposure across the energy value chain, from upstream production to drilling and field-development services.

International Investment Could Accelerate Venezuela’s Oil DevelopmentVenezuela holds a massive resource base, particularly in the Orinoco Belt, where much of the crude is heavy or extra-heavy oil. Developing these resources requires substantial capital, specialized technology, infrastructure and long-term field-development plans.

Recent agreements indicate that international companies are increasing their involvement. Greater international participation could increase spending on drilling, reservoir evaluation, production infrastructure and enhanced oil recovery. This could benefit both producers and oilfield service companies as Venezuela attempts to translate its large resource base into higher commercial production.

Eni: Junín-5 Provides a Large-Scale Growth OpportunityEni provides significant upstream angle through its Junín-5 development. Eni and PDVSA signed a 25-year hydrocarbon participation contract on Sept. 2, 2026, under which Eni became the exclusive operator of the Junín-5 area. The heavy-oil field contains 35 billion barrels of certified oil in place and currently produces approximately 12,000 barrels per day.  

Eni and PDVSA plan to invest approximately $1.5 billion annually in the project. Reuters reported that production is expected to reach around 400,000 barrels per day by 2030.

The project could therefore become an important source of future production growth for Eni. Its scale also illustrates the capital and technical expertise required to develop Venezuela’s heavy-oil resources.

Eni already has an established Venezuelan presence through assets including the Perla gas field and Corocoro oil field. This existing operating experience could support its role in additional Venezuelan development projects. Eni sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

TotalEnergies: Potential Return to Venezuelan OilTotalEnergies represents a different form of exposure because its latest Venezuelan initiative remains at an earlier stage. TotalEnergies and PDVSA signed a memorandum of understanding (MOU) on Sept. 19, 2026, establishing a framework for energy cooperation in Venezuela. Details regarding the scope and value of the agreement have not been disclosed, making it premature to quantify the potential production or financial contribution.

For investors, the key factor will be whether the MOU develops into specific projects and capital commitments. At this stage, the agreement signals renewed engagement rather than a defined production program. TotalEnergies carries a Zacks Rank #2 (Buy).

Chevron: Direct Exposure to Venezuelan Production GrowthChevron offers direct exposure to Venezuela’s potential production expansion. On Sept. 2, 2026, Chevron announced updated agreements covering its Venezuelan joint ventures and additional acreage in the Orinoco Belt. The agreements underpin plans to invest more than $7 billion over the next five years and more than double production to approximately 600,000 barrels per day compared with 2026 levels. Chevron also reported that production from its three Venezuelan joint ventures increased 15% through the second quarter of 2026.

The company’s long operating history in Venezuela and existing infrastructure provide an established platform for additional development. Higher production could increase upstream volumes and strengthen Chevron’s long-term production portfolio. Chevron currently carries a Zacks Rank #3 (Hold).

Halliburton: Rising Activity Could Support Oilfield ServicesHalliburton provides exposure through the oilfield services side of Venezuela’s potential revival. It announced MOUs with Eneva and WESCA on Sept. 21, 2026, to support energy development opportunities in Venezuela. Under the WESCA agreement, Halliburton will support field evaluation and development planning, while its agreement with Eneva is intended to identify and pursue additional development opportunities.

This provides Halliburton with potential exposure to increased drilling, reservoir evaluation and development activity. Unlike Chevron and Eni, whose opportunities are directly linked to production growth, Halliburton’s potential benefit depends more on the level of capital spending and field-development activity generated by Venezuela’s producers. HAL carries a Zacks Rank #3.

ConclusionVenezuela’s renewed appeal among international energy companies is creating an emerging investment theme across the oil and gas value chain. Higher capital spending and development activity could support production growth while creating additional demand for specialized oilfield services.

CVX provides direct exposure through its expanding Venezuelan production portfolio, while E has a major development opportunity through Junín-5. TTE offers potential exposure to a renewed Venezuelan presence, while HAL could benefit from higher field-development and service activity.

For investors, the key factor to watch is the conversion of agreements and investment plans into actual projects, production growth and sustained industry spending. Venezuela’s large resource base creates significant potential, but the financial impact on individual companies will depend on project execution, capital requirements, oil prices, infrastructure development and the evolution of the country’s operating environment.

 | Source: Applied Materials, Inc.

Besi joins Applied's EPIC Center as an Innovation Partner, extending a collaboration that began in 2020 with the companies' joint Hybrid Bonding Center of Excellence in SingaporeExpanded collaboration targets next-generation 3D IC scaling, logic and memory integration, and photonics applications supporting AI infrastructure build-outPartnership expands beyond die-to-wafer hybrid bonding to new hybrid bonding platforms, scaling of thermo-compression bonding (TCB), and new die-on-wafer, die-on-die and die-on-panel architectures SANTA CLARA, Calif. and DUIVEN, The Netherlands, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. (Nasdaq: AMAT) and BE Semiconductor Industries N.V. (Besi) (Euronext Amsterdam: BESI) today announced an expansion of their longstanding strategic partnership, with Besi joining Applied's EPIC Center as an Innovation Partner. The collaboration builds on the companies’ joint development program launched in 2020 and extends co-innovation beyond hybrid bonding into new interconnect architectures and applications supporting the semiconductor industry's AI-driven scaling roadmap.

As the AI infrastructure build-out drives demand for higher-density, higher-bandwidth chip-to-chip and chip-to-package interconnects, the expanded partnership is intended to give mutual customers earlier access to co-optimized process and assembly solutions spanning the full advanced packaging flow – from wafer-level hybrid bonding through panel-scale integration.

In 2020, Applied and Besi established a joint Center of Excellence at Applied's Advanced Packaging Development Center in Singapore, combining Applied's process expertise in etch, planarization, deposition, wafer cleaning, metrology, inspection and particle defect control with Besi's die placement, interconnect and assembly technology. That collaboration resulted in Kinex™, the industry’s first integrated die-to-wafer hybrid bonding system.

“Besi has been a trusted partner since we began co-developing next-generation hybrid bonding solutions,” said Gary Dickerson, President and CEO of Applied Materials. “With Besi joining EPIC as an Innovation Partner, we’re extending that collaboration across the interconnect technologies our customers need to scale AI systems. Bringing this work into Applied's EPIC Center gives both companies earlier visibility into where the roadmap is headed and lets us co-optimize the full packaging flow.”

“Our center of excellence with Applied in Singapore has been foundational to Besi's hybrid bonding roadmap,” said Richard Blickman, CEO and Chairman of the Board of Management of Besi. “Joining Applied's EPIC Center as an Innovation Partner is a natural next step, giving us a seat alongside the leading logic, memory and systems companies as we advance TCB scaling, die-on-panel integration and the interconnect technologies that will define the next generation of AI and photonics systems”

As an Innovation Partner, Besi engineers will work alongside Applied's teams at the EPIC Center to accelerate joint development across a broader set of interconnect and integration technologies. While advanced packaging was historically treated as a back-end assembly step, technologies such as hybrid bonding and panel-level integration now depend on the same materials engineering disciplines that define front-end wafer fabrication.

“Advanced packaging is no longer a back-end assembly step – it is a materials engineering challenge that demands the same precision and cleanliness as front-end wafer fabrication,” said Dr. Prabu Raja, President of the Semiconductor Products Group at Applied Materials. “Developing these technologies together with Besi engineers in a front-end R&D environment like the EPIC Center will allow us to treat them as one connected flow rather than a series of isolated steps. That gives our mutual customers earlier access to co-optimized solutions and a faster path from development to high-volume manufacturing.”

The expanded scope of collaboration will focus on next-generation 3D IC scaling and logic and memory integration for AI compute and memory architectures, with expected R&D programs to include:

New platforms for die-to-wafer hybrid bonding, building on the companies' existing Singapore Center of ExcellenceScaling of thermo-compression bonding (TCB) and its surrounding process ecosystemNew die-on-wafer, die-on-die and die-on-panel integration platformsPhotonics-enabled interconnect applications supporting co-packaged optics and AI system scaling Applied’s new, $5 billion* EPIC (Equipment and Process Innovation and Commercialization) Center in Silicon Valley represents the largest-ever U.S. investment in advanced semiconductor equipment and process technology R&D. The center, which will be operationally ready this year, is designed from the ground up to dramatically reduce the time it takes to commercialize breakthrough technologies from early-stage research to full-scale manufacturing.

*Capital spending is expected to scale over time to approximately $5 billion as customer projects commence.

About Applied Materials
Applied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions that are at the foundation of virtually every new semiconductor and advanced display in the world. The technology we create is essential to advancing AI and accelerating the commercialization of next-generation chips. At Applied, we push the boundaries of science and engineering to deliver material innovation that changes the world. Learn more at www.appliedmaterials.com.

Applied Materials Forward-Looking Statements
This press release contains forward-looking statements, including those regarding Applied's investment and growth strategies, the development of new materials and technologies, industry outlook and technology requirements, the plans and expectations for the EPIC Center, and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the demand for semiconductors and customers' technology requirements; the ability to develop new and innovative technologies; the ability to obtain and protect intellectual property rights in key technologies; the ability to achieve the objectives of the EPIC Center; and other risks and uncertainties described in Applied's filings with the Securities and Exchange Commission, including Applied's most recent Forms 10-K, 10-Q and 8-K. All forward-looking statements are based on management's current estimates, projections and assumptions, and Applied assumes no obligation to update them.

About Besi
Besi is a leading manufacturer of assembly equipment supplying a broad portfolio of advanced packaging solutions to the semiconductor and electronics industries. We offer customers high levels of accuracy, reliability and throughput at a lower cost of ownership with a principal focus on wafer level and substrate assembly solutions. Customers are primarily leading semiconductor manufacturers, foundries, assembly subcontractors and electronics and industrial companies. Besi’s ordinary shares are listed on Euronext Amsterdam (symbol: BESI). Its Level 1 ADRs are listed on the OTC markets (symbol: BESIY) and its headquarters are located in Duiven, the Netherlands. For more information, please visit our website at
www.besi.com.

Besi Forward-Looking Statements
This press release contains statements about management's future expectations, plans and prospects of our business that constitute forward-looking statements, which are found in various places throughout the press release, including, but not limited to, statements relating to expectations of orders, net sales, product shipments, expenses, timing of purchases of assembly equipment by customers, gross margins, operating results and capital expenditures. The use of words such as “anticipate”, “estimate”, “expect”, “can”, “intend”, “believes”, “may”, “plan”, “predict”, “project”, “forecast”, “will”, “would”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The financial guidance set forth under the heading “Outlook” contains such forward-looking statements. While these forward-looking statements represent our judgments and expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from those contained in forward-looking statements, including any inability to maintain continued demand for our products; failure of anticipated orders to materialize or postponement or cancellation of orders, generally without charges; the volatility in the demand for semiconductors and our products and services; failure to develop new and enhanced products and introduce them at competitive price levels; failure to adequately manage costs and expenses in line with revenue; loss of significant customers, including through industry consolidation or the emergence of industry alliances; lengthening of the sales cycle; acts of terrorism and violence; disruption or failure of our information technology systems; consolidation activity and industry alliances in the semiconductor industry that may result in further increased customer concentration, inability to forecast demand and inventory levels for our products; the integrity of product pricing and protection of our intellectual property in foreign jurisdictions; risks, such as changes in trade regulations, conflict minerals regulations, currency fluctuations, political instability and war, associated with substantial foreign customers, suppliers and foreign manufacturing operations, particularly to the extent occurring in the Asia Pacific region where we have a substantial portion of our production facilities; potential instability in foreign capital markets; the risk of failure to successfully manage our diverse operations; any inability to attract and retain skilled personnel, including as a result of restrictions on immigration, travel or the availability of visas for skilled technology workers; and the other risks detailed in the Risk Management section of our Annual Report. We expressly disclaim any obligation to update or alter these forward-looking statements for revisions or changes whether as a result of new information, future events or otherwise after the date of this release.

In addition, the United States and other countries have recently levied tariffs and taxes on certain goods and could significantly increase or impose new tariffs on a broad array of goods. They have imposed, and may continue to impose, new trade restrictions and export regulations. Increased or new tariffs and additional taxes, including any retaliatory measures, trade restrictions and export regulations, could negatively impact end-user demand and customer investment in semiconductor assembly equipment, increase Besi’s supply chain complexity and manufacturing costs, decrease margins, reduce the competitiveness of our products or restrict our ability to sell products, provide services or purchase necessary equipment and supplies. Any or all of the foregoing factors could have a material and adverse effect on our business, results of operations or financial condition. In addition, investors should consider those additional risk factors set forth in Besi's annual report for the year ended December 31, 2025 and other key factors that could adversely affect our businesses and financial performance contained in our filings and reports, including our statutory consolidated statements. We expressly disclaim any obligation to update or alter our forward-looking statements whether as a result of new information, future events or otherwise.

Contacts:

Applied Materials
Ricky Gradwohl (editorial/media) 408.235.4676
Mike Sullivan (financial community) 408.986.7977

Besi
Richard W. Blickman, President & CEO 
Andrea Kopp-Battaglia, Senior Vice President Finance  
Claudia Vissers, Executive Secretary/IR coordinator 
Edmond Franco, VP Corporate Development/US IR coordinator 
Tel. (31) 26 319 4500, [email protected]    

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DICK'S Sporting Goods, Inc. ("Dick's" or the "Company") (NYSE: DKS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Dick's and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until November 3, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Dick's securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. 

[Click here for information about joining the class action]

On September 8, 2025, Dick's announced the completion of its acquisition of Foot Locker, Inc. ("Foot Locker"), a prominent footwear and apparel retailer, for approximately $2.5 billion in cash and stock.

On August 25, 2026, before the market opened, Dick's issued a press release announcing its financial results for the second quarter of 2026.  Specifically, the Company reported adjusted earnings per share of $3.53 per share, which fell short of analysts' estimates of $3.76 per share.  Notably, Dick's also disclosed that Foot Locker generated revenue of only $1.73 billion, significantly below analysts' expectations of $1.81 billion.  The Company also reduced its full-year 2026 consolidated net sales guidance to a range between $21.9 billion to $22.2 billion (down from $22.1 billion to $22.4 billion).  Dick's further revealed that it expected Foot Locker's proforma comparable sales to yield a range of negative 2.0% to 0.0% for the year – a sharp deterioration from Dick's prior forecast of 1.5% to 3% growth for Foot Locker.

In the press release, Executive Chairman Edward Stack conceded that "[a]s the quarter progressed, conditions across portions of the athletic footwear and apparel marketplace became increasingly promotional, and we took action to remain competitively priced."  Stack further explained that this environment had a more "significant impact" on Foot Locker due to its "greater exposure to legacy footwear silhouettes and greater dependence on footwear launch and retro product."  Stack also noted that "[n]ot only were there fewer launches in the second quarter, but those launches performed below both industry and our expectations."

Following these disclosures, Dick's stock price fell $55.02 per share, or approximately 30%, to close at $124.31 per share on August 25, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

GREENWICH, Conn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, today announced the opening of two new service centers in Mesa, Arizona, and Cameron, Missouri. The facilities expand XPO’s capacity to meet growing freight demand in the Phoenix and Kansas City metropolitan areas.

Matt Carroll, president of XPO’s West Division, said, “These new service centers deepen our presence in two critical freight markets and reflect our strategic approach to investing in our network. We’ve added capacity where our customers need it most, positioning us to support their growth while delivering the world-class service they count on.”

The 51,000-square-foot Mesa facility has 86 dock doors and a team of more than 100 employees. Located in one of the nation’s largest and fastest-growing metropolitan areas, it complements XPO’s existing Phoenix service center, adding capacity to meet increasing freight demand fueled by industrial investment and cross-border trade with Mexico.

The 13,000-square-foot Cameron service center has 32 dock doors and a team of more than 30 employees. Located at the intersection of two major highways, I-35 and U.S. 36, it enables more efficient freight movement along key north-south and east-west freight corridors in the Midwest.

XPO has opened nearly 35 new service centers across the country since 2021, expanding its network dock door capacity by 15%. Construction at the Mesa and Cameron sites was completed this summer, and their openings bring XPO’s North American network to 300 service centers, which provide direct service to 99% of U.S. ZIP codes and cross-border service to and from Canada and Mexico.

About XPO
XPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company’s customer-focused organization efficiently moves 16 billion pounds of freight per year, enabled by its proprietary technology. XPO serves 55,000 customers with 586 locations and 38,000 employees in North America and Europe, and is headquartered in Greenwich, Conn., USA. Visit xpo.com for more information, and connect with XPO on LinkedIn, Facebook, X, Instagram and YouTube.

Investor Contact
Brian Scasserra
+1-617-607-6429
[email protected]

Media Contact
Cole Horton
+1-203-609-6004
[email protected]

Meta's new shopping agent rattled online travel stocks almost equally, but Booking Holdings and Expedia chose opposite responses to the threat. One strategy leaves a company dangerously exposed if Meta decides to cut out the middleman entirely.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Meta Platforms (NASDAQ:META | META Price Prediction) launched Muse, a shopping agent that reached 560,000 daily active users within 11 days.

Truist then cut price targets on Booking Holdings (NASDAQ:BKNG) and Expedia Group (NASDAQ:EXPE) on the same day, citing Muse.

Both online travel agencies (OTAs) kept their ratings. Booking stayed at Buy with its target cut from $242 to $216, and Expedia stayed at Hold with its target cut from $309 to $288. The two companies responded to Muse differently, and Booking’s approach likely holds up better.

Expedia Joined Muse While Booking Kept Its Direct Channel Expedia partnered with Muse and is integrated for travel booking there. That suits a company whose B2B revenue, which powers other brands’ travel sites, grew 23% last quarter.

Booking stayed out. Its consumer direct mix held in the mid-60% range for four quarters, and large language models send “significantly below one percent” of its room nights.

Partnering risks teaching Meta how travelers shop, which could help it bypass Expedia later, and declining risks missing agent-first travelers, a smaller cost while that traffic stays tiny.

Independent Hotels Keep Booking Essential to AI Agents The same firm estimated that only about 10% of Booking’s room nights come from the top global hotel brands. Big chains run loyalty programs and booking systems an AI agent can plug into directly, but independent hotels lack that technology, so an agent seeking their rooms still needs Booking. Booking also processes payment on approximately 73% of gross bookings, which keeps it inside the transaction.

Both stocks have already absorbed similar damage.

Booking fell 17.98% over the past month, and Expedia fell 16.95%, nearly identical damage. Booking’s 25-to-1 stock split effective April 2, 2026 explains why its $162.91 shares look small beside Expedia’s $263.36. On forward earnings, Booking trades at 13 times and Expedia at 11 times.

Target Cuts Came With an Admission of Uncertainty The firm warned that Meta poses “greater downside risks to OTAs given the company’s strong consumer position,” but admitted the “extent to which Muse or other AI agents will affect OTA bookings share remains highly uncertain.”

Retail shows the same split: Amazon (NASDAQ:AMZN) blocked Muse, while Walmart (NASDAQ:WMT), Wayfair (NYSE:W) and Sephora joined as launch partners. Meta’s chief executive said Meta will profit from a small transaction fee, a toll that would likely come out of travel sellers’ margins.

Booking Looks Better Positioned to Withstand Muse Booking looks better placed of the two. Revenue of $7.35 billion beat estimates, Transformation Program savings now target about $650 million by the end of 2027, and its hotel base sits further from Muse.

Expedia posted 14% revenue growth and raised guidance, but its partnership strategy leaves it more exposed if Meta’s fee pressures partner economics.

My view changes if Booking reports large language model traffic climbing well above 1% of room nights. Pair that with a direct mix sliding below the mid-60s, and Booking would be paying for customers it once owned.

Contact [email protected] for any questions or corrections.

Key Takeaways Neogen's Food Safety revenues rose 3.1%, with core growth reaching 5.8% in fiscal 2026's fourth quarter.Petrifilm remains a key asset as Neogen brings manufacturing in-house and expands its product platform.Neogen plans to boost fiscal 2027 R&D spending 50%, targeting pathogen detection and sanitation platforms. Neogen (NEOG - Free Report) shares have shown impressive momentum so far this year, surging 83%. The stock has outpaced the industry’s 21.6% fall and the S&P 500 composite’s 11.7% rise.  

Carrying a Zacks Rank #2 (Buy) at present, the company’s Food Safety strength and solutions-based selling strategy are supporting growth momentum and portfolio expansion. Neogen is expanding its product and manufacturing capabilities following the 3M Food Safety combination, with Petrifilm playing a key role. It also continues to expand its product pipeline with new launches and differentiated technologies.

Neogen develops, manufactures and markets a diverse line of products and services dedicated to food and animal safety. The company’s Food Safety segment markets diagnostic solutions, test kits, culture media and complementary products used to detect foodborne pathogens, natural toxins, allergens and sanitation concerns. Its Animal Safety portfolio includes life sciences products, veterinary instruments and disposables, animal care products, pest control solutions and genomics services. In March 2026, Neogen agreed to sell its Genomics business to Zoetis for $160 million, subject to regulatory approvals and customary closing conditions.

Factors Supporting NEOG’s Price RallyThe rally in the company’s share price can be linked to the continued momentum in Neogen’s Food Safety segment, its central growth engine, which is supported by a broad portfolio spanning indicator testing, culture media, pathogen detection and sanitation. In the fourth quarter of fiscal 2026, segment revenues jumped 3.1% year over year, while core growth reached 5.8%, the highest quarterly rate since fiscal 2023. Indicator Testing and Culture Media revenues rose 9.5%, while Bacterial and General Sanitation increased 9.9%.

Image Source: Zacks Investment Research

The company is also shifting toward global solutions-based selling, with resources focused on strategic accounts, disciplined segmentation and higher-return geographies. Management expects this model to deepen portfolio penetration and improve customer engagement. 

Neogen’s 2022 combination with 3M’s Food Safety business continues to expand its product breadth and manufacturing capabilities, with Petrifilm remaining a key strategic asset. The company is bringing Petrifilm manufacturing in-house at its Lansing facility. The new manufacturing platform is also designed to support broader innovation, including additional Petrifilm SKUs and expansion into pharmaceuticals, nutraceuticals and consumer products.

Neogen continues to expand its product pipeline across Food and Animal Safety while directing more resources toward differentiated technologies. Recent launches include Neogen MPNTray, the Listeria Right Now molecular detection assay, Igenity BCHF and MDA2 Quantitative Salmonella. Listeria Right Now received AOAC Performance Tested Methods certification in fiscal 2026, supporting broader commercial use of the enrichment-free environmental monitoring test.

Strategically, the company is advancing a three-part transformation centered on commercial execution, innovation and operational efficiency. The commercial program is moving from local product-led selling toward a global solutions-based model, with sales resources being realigned around priority countries, customer segments and strategic accounts. Neogen expects fiscal 2027 research and development (R&D) spending to rise about 50% from fiscal 2026, focused on Petrifilm, informatics, technology licensing and next-generation platforms in pathogen detection and general sanitation.

What Ails NEOG?Historically, Neogen has faced intense competition resulting from the development of new technologies by the company’s competitors, which could affect the marketability and profitability of its products. It also remains materially exposed to foreign currency fluctuations, with international sales accounting for 51.2% of fiscal 2026 revenues.

A Glance at NEOG’s EstimatesThe Zacks Consensus Estimate for NEOG’s fiscal 2027 earnings per share (EPS) is expected to drop 3.1% from 2026 to 31 cents. In the past 60 days, the estimate has risen 1 cent. Meanwhile, fiscal 2028 EPS is projected to grow 17.2% to 36 cents.

The company’s fiscal 2027 revenues are projected to rise 1.5% to $883.2 million, while fiscal 2028 revenues are expected to fall 4.2% to $846.5 million.

Other Key PicksSome other top-ranked stocks in the broader medical space are Veracyte (VCYT - Free Report) , Phibro Animal Health (PAHC - Free Report) and Globus Medical (GMED - Free Report) .

Veracyte has an earnings yield of 4.7% against the industry’s negative 1.4% yield. Shares of the company have risen 29.1% compared with the industry’s 8.2% growth. VCYT’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 41.8%. 

VCYT sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Phibro Animal Health, sporting a Zacks Rank #1, has an earnings yield of 10.2% compared with the industry’s 2.5% yield. Its earnings beat estimates in each of the trailing four quarters, the average surprise being 18.4%. PAHC shares have fallen 8.2% against the industry’s 27.7% decline over the past year.

Globus Medical, sporting a Zacks Rank #1, has an earnings yield of 6.8% against the industry’s negative 1.7% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 27.9%. GMED shares have rallied 29% compared with the industry’s 8.3% growth over the past year.

Vancouver, British Columbia--(Newsfile Corp. - October 1, 2026) - Canagold Resources Ltd. (TSX: CCM) (OTCQB: CRCUF) (FSE: CANA) ("Canagold" or the "Company") announces assay results from five drill holes completed as part of its recently concluded 14-hole resource infill and expansion drilling program targeting the high-grade antimony zone at its 100%-owned New Polaris Gold Project, located in northwestern British Columbia ("BC"), approximately 100 kilometres (km) south of Atlin, BC, and 60 km northeast of Juneau, Alaska.

The drill program was designed to further define and expand the high-grade antimony mineralization identified at New Polaris, while also evaluating its potential to contribute to the Project's gold resources. Highlights of the antimony and gold mineralization intersected in the five drill holes are summarized below, with complete drill-hole results and locations provided in Table 1 and Figure 1.

Highlights

3.83% Sb and 19.38 Au grams per tonne (g/t) Au over 13.20 meters (m) from 451.75 m down hole in hole NP26-01 including 1.21 m grading 30.46% Sb and 49.10 g/t Au. 3.90% Sb and 14.97 g/t Au over 6.06 m from 477.44 m down hole in hole NP26-02 including 0.83 m grading 24.68 % Sb and 29.0 g/t Au.3.30% Sb and 15.08 g/t Au over 3.91 m from 451.19 m down hole in hole NP26-03 including 1.81 m grading 6.99% Sb 26.3 g/t Au."These results are highly significant for New Polaris, representing the highest Sb grades over the greatest widths encountered at the Project to date," stated Catalin Kilofliski, Canagold's CEO. "Importantly, they suggest that the scale of the Sb mineralization may be substantially larger than we originally understood. This creates an opportunity to significantly expand the high-grade Sb and gold resources and, importantly, positions Sb as having the potential to become a meaningful contributor to the overall value and economics of New Polaris."

Table 1

Drill holeFrom (m)To (m)Interval (m)Sb (%)Au (g/t)NP26-01451.75464.9513.203.8319.38Including455.00456.211.2130.4649.10NP26-02477.44483.506.063.9014.97Including478.22479.050.8324.6829.00NP26-02487.50490.352.850.1117.10NP26-03451.19455.103.913.3015.08Including451.19453.001.816.9926.3NP26-05488.83493.564.731.505.76Including490.83491.560.738.5012.80*The New Polaris resource is contained within an Updated Resource report which was prepared by Moose Mountain Technical Services in the format prescribed by NI43-101 Standards of Disclosure for Mineral Projects, and filed on Sedar June 30,2023.

Additional Drilling Highlights

Hole IDInterval
* (m)Sb %Au (gpt)From (m)NP26-022.85 m0.1017.1gpt487.5 mNP26-06B8.22 m0.0116.47gpt472.6 mDrill Hole Details

Hole IDUTM E
NAD83UTM N
NAD83Elev
(m)Azi
(deg)Dip
(deg) Depth
(m)NP26-0157933065070773090.68 -83.18479NP26-02579330650707730101.23-83.73515NP26-03579322650711032103.19-83.7480NP26-05579330650707730111.48-78.04516NP26-06B57933065070773079.71-86.25522Drill intercepts shown are core length as insufficient drilling and modelling has taken place to determine the true dip and strike orientation of the veins being intercepted.

Figure 1

The drilling program has been completed with 7,277m being drilled in 14 holes. The drilling has intersected multiple zones of mineralization in this area.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11878/316852_aeea4c1f842e3ab4_001full.jpg

Drill Core Sampling and Quality Assurance – Quality Control Program

Drill core is geologically logged to identify the gold mineralized zones that are allocated unique sample number tickets and marked for cutting using a purpose-built diamond blade rock saw. Half core samples are collected in labelled bags and the other half remains in the original core box stored on site. Quality control (QC) samples including certified reference material standards, blanks and duplicates are inserted into the sample sequence at intervals of one in ten on a rotating basis to monitor laboratory performance and provide quality assurance (QA) of the assay results. Several sample bags are transported together in rice bags with unique numbered security tags attached and labelled with Company and lab contact information to ensure sample security and chain of custody during shipment to the lab.

Diamond drill core samples were prepared at MSA Labs' Preparation Laboratory in Terrace, BC and assayed at MSA Labs' Geochemical Laboratory in Langley, BC. Analytical accuracy and precision are monitored by the submission of blanks, certified standards and duplicate samples inserted at regular intervals into the sample stream by Canagold personnel. MSA Laboratories quality system complies with the requirements for the International Standards ISO 17025 and ISO 9001. MSA Lab is independent of the Company.

Qualified Person

In accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects, Garry Biles, P.Eng, President & COO is the Qualified Person for the Company and has prepared, validated, and approved the technical and scientific content of this news release. The Company strictly adheres to CIM Best Practices Guidelines in conducting, documenting, and reporting activities on its projects.

About Canagold

Canagold Resources Ltd. is an advanced development company dedicated to advancing the New Polaris Project through feasibility, permitting, and production stages. Additionally, Canagold aims to expand its asset base by acquiring advanced projects, positioning itself as a leading project developer. With a team of technical experts, the Company is poised to unlock substantial value for its shareholders.

"Catalin Kilofliski"

Catalin Kilofliski
Chief Executive Officer

Website: www.canagoldresources.com

Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/316852

Source: Canagold Resources Ltd.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Marvell just posted record revenue and raised guidance, yet its stock sits nearly 20% off its highs while AI sentiment drags it lower. Three upcoming catalysts could determine whether this gap closes or widens.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction) trades at $264.21, and pullbacks have tested the stock’s momentum. A sector-wide slide in AI hardware names this week, after a 214.95% one-year run, makes this the moment to settle on a view.

Marvell designs custom AI chips, optical interconnects and Ethernet switches for hyperscale data centers. Data Center revenue hit $2.17 billion last quarter, up 46% year over year and now 79% of sales. Record total revenue of $2.739 billion exceeded estimates. Management also raised guidance and expanded its custom silicon deal with Google parent Alphabet (NASDAQ:GOOGL), which includes a warrant for up to 7% of Marvell’s shares tied to revenue milestones.

Accelerating Growth Drives a Wave of Estimate Hikes Third-quarter revenue guidance of $3.15 billion implies more than 50% growth at the midpoint, with Data Center up roughly 75%. Fiscal 2027 revenue is now expected near $12 billion, and fiscal 2028 growth was raised to approximately 50%. Management expects the custom business to more than double in fiscal 2028.

Analysts have raised estimates. The fiscal 2028 EPS consensus rose to $6.7609 from $6.2425 a month ago, with 33 upward revisions against one cut. A PEG ratio of 1.387 suggests growth justifies the premium, and the upcoming Investor Day should measure the Google opportunity beyond fiscal 2028.

Premium Multiple Leaves Little Room for Stumbles Shares trade at 83x trailing earnings with a beta of 2.253, so any wobble in AI spending hits hard. A handful of hyperscalers drive revenue, and customers could build more silicon in-house. Third-quarter non-GAAP gross margin guidance of 57.5% to 58.5% reflects mix pressure from the custom ramp.

The $120 billion cumulative Google figure depends on milestones, and the warrant means dilution if those milestones are hit. Stock-based compensation rose to $207.6 million in the first quarter from $142.1 million a year earlier, alongside $4.963 billion of long-term debt.

Investor Day Detail Could Decide the Next Move Recent beats were narrow, with revenue just 1.20% above consensus. The stock still sits 19.9% below its $329.8 52-week high, a sign that enthusiasm has already cooled once. Investors will look for fiscal 2029 custom targets and confirmation that the business delivers $1.05 to $1.15 in third-quarter EPS while communications revenue dips.

Wall Street Still Sees Upside After a Triple-Digit Run The consensus target of $290.97 implies 10.1% upside from $264.21 across 44 analysts. Targets are one data point, and they can lag fast-moving stocks.

Strong Buy: 8 Buy: 31 Hold: 5 Sell: 0 Marvell is up 211.36% year to date versus 11.81% for the S&P 500. Over the past month it gained 24.83% while the index slipped 0.6%. The forward P/E stands at 62x. Runs like this are what we reverse-engineered in a free playbook on spotting the next Nvidia-style winner early.

Custom Silicon Scaling Sets Up Three Key Catalysts Marvell trades at $264.21.

The path higher runs through three catalysts: Investor Day details on fiscal 2029 custom revenue, a third-quarter report that confirms growth above 50%, and operating margin reaching the 38% to 40% target range in the fourth quarter. Each one helps earnings catch up to the multiple.

Volatility comes with the stock. Selloffs driven by sector sentiment, like this week’s slide in AI names, have pressured shares of a business whose estimates keep moving up.

The thesis breaks if hyperscalers cut capital spending, custom ramps slip, or margins fall below guidance. Keep an eye on gross margin and Data Center growth each quarter.

Rising estimates and a expanding custom pipeline keep fundamentals at the center of the Marvell story as sentiment-driven dips come and go.

Contact [email protected] for any questions or corrections.

It cost bitcoin miners an average of about $75,500 in cash to produce one coin in the second quarter. Meanwhile, bitcoin itself ended June at $58,400, less than half its October 2025 record high. That gap pushed publicly traded miners below cash breakeven as a group, according to CoinShares’ Q2 2026 Bitcoin Mining Report by Luke Nolan. Cash cost covers day-to-day spending such as power, staff and interest, but not equipment wear.

Key Takeaways: Listed miners spent about $75,500 in cash per bitcoin last quarter, well above the coin’s June close. Grid delays and state restrictions have turned existing power connections into a scarce asset for AI data centers. WGMI broadened its strategy in August to include data centers, AI chipmakers and power producers alongside miners. See more: Why Bitcoin Miners Stopped Tracking Bitcoin’s Price

Rather than wait out the slump, many miners are renting their power sites to AI and high-performance computing (HPC) customers. The report estimates AI computing earns about $1.5 million in yearly profit per megawatt of power, versus $0.5 million for mining.

The shift is changing what investors own when they buy mining stocks. Companies with signed AI or HPC contracts traded at an average 12.9 times expected sales for the next year, the report found. Miners without such contracts, by contrast, averaged 3.7 times. In other words, the market values those miners at less than a third as much per dollar of sales.

Power is now the scarce resource. At least 151 restrictions on data center development remain in force across the U.S., the report showed. New York, for example, enacted the first statewide pause on permits for large data centers in July.

Power projects totaling about 2,600 gigawatts are also waiting to connect to the U.S. grid, the report said. That backlog is roughly double the grid’s installed capacity.

As a result, prices have climbed for sites that already have power. A $3.5 billion deal for three leased Northern Virginia AI facilities worked out to about $27 million per megawatt, the report noted. By comparison, the market values some listed miners’ powered but unleased sites at less than $3 million per megawatt.

Bitcoin Miners Pay to Stop Mining Some companies are paying to exit. Core Scientific, Inc. (CORZ) paid $41.9 million to cancel an order for next-generation mining chips, according to the report. Those chips are the most efficient mining hardware produced to date.

Mining brings in about 13% of the company’s revenue as it converts sites for AI use, the report said. Its remaining machines run at a loss, only to use up power it has already agreed to buy.

Keel Infrastructure Corp. (KEEL), formerly Bitfarms, stopped mining on June 29, according to the report. That makes it the first listed miner headed for zero mining revenue, starting in the third quarter.

At IREN Ltd. (IREN), AI cloud revenue of $70.5 million topped mining revenue of $66.7 million for the first time, per the report.

Most of the sector’s contracted AI revenue has not arrived yet, though. More than $100 billion in disclosed contracts supports only about $1.1 billion in yearly AI and HPC revenue, according to the report.

Several of these miners anchor the CoinShares Bitcoin Mining and Digital Power ETF (WGMI). Eight of the report’s 12 companies ranked among its top 10 holdings as of September 29, CoinShares data show.

On August 18, the fund broadened its strategy to include data center operators, AI chipmakers, power producers and HPC firms. The actively managed ETF does not, however, hold bitcoin directly, CoinShares said.

WGMI held $291.5 million in assets as of September 28 and charges a 0.75% expense ratio, according to CoinShares.

Cipher Digital Inc. (CIFR), the fund’s largest holding, will likely exit mining by the end of 2027, the report said. In the first half, it sold $123.4 million of bitcoin at a $47.7 million loss to help fund buildings for data center tenants.

For more news, information, and strategy, visit the CoinShares Crypto ETF Hub.